{"title": "PDF", "author": "PDF", "url": "https://www.healthpartners.com/ucm/groups/public/@hp/@public/documents/documents/entry_213453.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Group (PPO) HealthPartners\u00ae Retiree National Choice (PDP) (Collectively known as HealthPartners) 2020 Formulary II __________________________________________________________________________________________________________________________________________ (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Fo rmulary ID 00020203 , Version 7 T his formulary was updated on 08/27/2019. For more recent information or other questions, please contact HealthPartners Member Services. Freed om members: 952-883-7979 users: 711 O r visit healthpartners.com/medicarerx . From Oct. 1 through March 31 , we take calls from 8 a.m. to 8 p.m. CT, seven days a week . You'll speak with a representative. From April 1 t hrough Sept. 30, call us 8 a.m. to 8 p.m. CT, Monday through Friday to speak with a representative. On Saturdays, Sundays and Federal holidays, you can leave a message and we'll get back to you within one business day. 1 9-435555 (01/20)I-2Note to existing members: This formulary has changed since last year. Please review this document to make sure that it still contains the drugs you take. When this drug list (formulary) refers to \"we,\" \"us\" or \"our,\" it means HealthPartners. When it refers to \"plan\" or \"our plan,\" it means HealthPartners. This document includes a list of the drugs (formulary) for our plan which is current as of August 27, 2019 . For an updated formulary, please contact us. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. You must generally use network pharmacies to use your prescription drug benefit. Benefits, formulary, pharmacy network, and/or copayments/coinsurance may change on January 1, 2021, and from time to time during the year. What is the HealthPartners Formulary? A formulary is a list of covered drugs selected by HealthPartners in consultation with a team of health care providers, which represents the prescription therapies believed to be a necessary part of a quality treatment program. HealthPartners will generally cover the drugs listed in our formulary as long as the drug is medically necessary, the prescription is filled at a HealthPartners network pharmacy and other plan rules are followed. For more information on how to fill your prescriptions, please review your Evidence of Coverage. Can the Formulary (drug list) change? Most changes in drug coverage happen on January 1, but we may add or remove drugs on the Drug List during the year, move them to different cost-sharing tiers, or add new restrictions. We must follow Medicare rules in making these changes. Changes that can affect you this year In the below cases, you will be affected by coverage changes during the year: New generic drugs. We may immediately remove a brand name drug on our Drug List if we are replacing it with a new generic drug that will appear on the same or lower cost-sharing tier and with the same or fewer restrictions. Also, when adding the new generic drug, we may decide to keep the brand name drug on our Drug List, but immediately move it to a different cost-sharing tier or add new restrictions. If you are currently taking that brand name drug, we may not tell you in advance before we make that change, but we will later provide you with information about the specific change(s) we have made. oIf we make such a change, you or your prescriber can ask us to make an exception and continue to cover the brand name drug for you. The notice we provide you will also include information on how to request an exception, and you can al so find information in the section below entitled \"How do I request an exception to the HealthPartners Formulary?\" D rugs removed from the market. If the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug's manufacturer rem oves the drug from the market, we will immediately remove the drug from our formulary and provide notice to members who take the drug. O ther changes. We may make other changes that affect members currently taking a drug. For instance, we may add a generic drug that is not new to market to replace a brand name drug currently on the formulary or add new restrictions to the brand name drug or move it to a different cost-sharing tier. Or we may make changes based on new clinical guidelines. If we remove drugs from our formulary, add prior authorization, quantity limits and/or step therapy restrictions on a drug or move a drug to a higher cost- sharing tier, we must notify affected members of the change at least 30 days before the change becomes effective, or at the time the member requests a refill of the drug, at which time the member will receive a 30-day supply of the drug.I-3oIf we make these other changes, you or your prescriber can ask us to make an exception and continue to cover the brand name drug for you. The notice we provide you will also include information on how to request an exception, and you can also find information in the section below entitled \"How do I request an exception to the HealthPartners Formulary?\" Changes that will not affect you if you are currently taking the drug Generally, if you are taking a drug on our 2020 formulary that was covered at the beginning of the year, we will not discontinue or reduce coverage of the drug during the 2020 coverage year except as described above . This means these drugs will remain available at the same cost-sharing and with no new restrictions for those members taking them for the remainder of the coverage year. The enclosed formulary is current as of August 27, 2019. To get updated information about the drugs covered by HealthPartners, please contact us. Our contact information appears on the front and back cover pages. To find out what drugs might have changed, you can go to healthpartners.com/medicarerx . The formulary is updated monthly to include any changes. In the event of negative formulary changes, you'll get a Formulary Change Notice. This notice will be mailed with your monthly Explanation of Benefits and will also be posted on our website. How do I use the Formulary? There are two ways to find your drug within the formulary: Medical Condition The formulary begins on page 1. The drugs in this formulary are grouped into categories depending on the type of medical conditions that they are used to treat. For example, drugs used to treat a heart condition are listed under the category \"Cardiac Drugs.\" If you know what your drug is used for, look for the category name in the list that begins on page 1. Then look under the category name for your drug. Alphabetical Listing If you are not sure what category to look under, you should look for your drug in the Index that begins on page 86. The Index provides an alphabetical list of all of the drugs included in this document. Both brand name drugs and generic drugs are listed in the Index. Look in the Index and find your drug. Next to your drug, you will see the page number where you can find coverage information. Turn to the page listed in the Index and find the name of your drug in the first column of the list. What are generic drugs? HealthPartners covers both brand name drugs and generic drugs. A generic drug is approved by the FDA as having the same active ingredient as the brand name drug. Generally, generic drugs cost less than brand name drugs. Are there any restrictions on my coverage? Some covered drugs may have additional requirements or limits on coverage. These requirements and limits may include: Prior Authorization: HealthPartners requires you or your physician to get prior authorization for certain drugs. This means that you will need to get approval from HealthPartners before you fill your prescriptions. If you don't get approval, HealthPartners may not cover the drug. Quantity Limits: For certain drugs, HealthPartners limits the amount of the drug that HealthPartners will cover. For example, HealthPartners provides 12 tablets per prescription for Sumatriptan. This may be in addition to a standard one-month or three-month supply. Step Therapy: In some cases, HealthPartners requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and DrugI-4B both treat your medical condition, HealthPartners may not cover Drug B unless you try Drug A first. If Drug A does not work for you, HealthPartners will then cover Drug B. You can find out if your drug has any additional requirements or limits by looking in the formulary that begins on page 1. You can also get more information about the restrictions applied to specific covered drugs by visiting our website. We have posted online documents that explain our prior authorization and step therapy restrictions. You may also ask us to send you a copy. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. You can ask HealthPartners to make an exception to these restrictions or limits, or for a list of other similar drugs that may treat your health condition. See the section \"How do I request an exception to the HealthPartners formulary?\" on page I-4 for information about how to request an exception. What if my drug is not on the Formulary? If your drug is not included in this formulary (list of covered drugs), you should first contact Member Services and ask if your drug is covered. If you learn that HealthPartners does not cover your drug, you have two options: You can ask Member Services for a list of similar drugs that are covered by HealthPartners. When you receive the list, show it to your doctor and ask him or her to prescribe a similar drug that is covered by HealthPartners. You can ask HealthPartners to make an exception and cover your drug. See below for information about how to request an exception. How do I request an exception to the HealthPartners Formulary? You can ask HealthPartners to make an exception to our coverage rules. There are several types of exceptions that you can ask us to make. You can ask us to cover a drug even if it is not on our formulary. If approved, this drug will be covered at a pre-determined cost-sharing level, and you would not be able to ask us to provide the drug at a lower cost-sharing level. You can ask us to cover a formulary drug at a lower cost-sharing level if this drug is not on the specialty tier. If approved this would lower the amount you must pay for your drug. You can ask us to waive coverage restrictions or limits on your drug. For example, for certain drugs, HealthPartners limits the amount of the drug that we will cover. If your drug has a quantity limit, you can ask us to waive the limit and cover a greater amount. Generally, HealthPartners will only approve your request for an exception if the alternative drugs included on the plan's formulary, the lower cost -sharing drug or additional utilization restrictions would not be as effective in treating your condition and/or would cause you to have adverse medical effects. You should contact us to ask us for an initial coverage decision for a formulary, tiering or utilization restriction exception. When you request a formulary, tiering or utilization restriction exception you should submit a statement from your prescriber or physician supporting your request. Generally, we must make our decision within 72 hours of getting your prescriber's supporting statement. You can request an expedited (fast ) exception if you or your doctor believe that your health could be seriously harmed by waiting up to 72 hours for a decision. If your request to expedite is granted, we must give you a decision no later than 24 hours after we get a supporting statement from your doctor or other prescriber. I-5What do I do before I can talk to my doctor about changing my drugs or requesting an exception? As a new or continuing member in our plan you may be taking drugs that are not on our formulary. Or, you may be taking a drug that is on our formulary but your ability to get it is limited. For example, you may need a prior authorization from us before you can fill your prescription. You should talk to your doctor to decide if you should switch to an appropriate drug that we cover or request a formulary exception so that we will cover the drug you take. While you talk to your doctor to determine the right course of action for you, we may cover your drug in certain cases during the first 90 days you are a member of our plan. For each of your drugs that is not on our formulary or if your ability to get your drugs is limited, we will cover a temporary 30- day supply. If your prescription is written for fewer days, we'll allow refills to provide up to a maximum 30-day supply of medication. After your first 30-day supply, we will not pay for these drugs, even if you have been a member of the plan less than 90 days. If you are a resident of a long-term care facility and you need a drug that is not on our formulary or if your ability to get your drugs is limited, but you are past the first 90 days of membership in our plan, we will cover a 31-day emergency supply of that drug while you pursue a formulary exception. Transition process For existing members in our plan who have changes in level of care, such as entering a long-term care facility or being discharged from a hospital, we'll grant early refills when appropriate. To ask for a temporary supply, contact Member Services. Please note that our transition policy only applies to drugs that are covered under the Part D benefit and bought at a network pharmacy, unless you qualify for out of network access. For more information For more detailed information about your HealthPartners prescription drug coverage, please review your Evidence of Coverage and other plan materials. If you have questions about HealthPartners, please contact us. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. If you have general questions about Medicare prescription drug coverage, please call Medicare at 1-800-MEDICARE (1-800- 633-4227) 24 hours a day/7 days a week. TTY users should call 1- 877-486-2048. Or, visit http://www.medicare.gov .I-6HealthPartners Formulary The formulary that begins on page 1 provides coverage information about the drugs covered by HealthPartners. If you have trouble finding your drug in the list, turn to the Index that begins on page 86. The first column of the chart lists the drug name. Brand name drugs are capitalized (e.g., HUMALOG) and generic drugs are listed in lower-case italics (e.g., atorvastatin ). The information in the Requirements/Limits column tells you if HealthPartners has any special requirements for coverage of your drug. The second column of the chart lists the drug tier or coverage level. HealthPartners covers Medicare Part D prescription drugs at five levels of coverage: Tier 1 (Preferred Generic), Tier 2 (Generic), Tier 3 (Preferred Brand), Tier 4 (Non-preferred drugs), and Tier 5 (Specialty). To determine the coverage level, locate your drug and look in the \"Drug Tier\" column. Then use the key below to determine your cost -sharing during the initial coverage phase for a 30-day supply .* COST-SHARING LEVELS BY PLAN AND DRUG TIER KEY Tier 1 (Preferred Generic Drugs) Tier 2 (Generic Drugs) Tier 3 (Preferred Brand Drugs) Tier 4 (Non -preferred Brand Drugs) Tier 5 (Specialty Drugs) Freedom Group Please refer to your Evidence of Coverage for more information about your prescription drug benefit, including drug tiers, cost sharing and drugs covered in the coverage gap. Journey Group Retiree National Choice * Coverage level shown does not reflect deductibles, gap coverage, or catastrophic benefit coverage. Please refer to our Evidence of Coverage for details.I-7The key below describes the abbreviations used in the Requirements/Limits column. Requirements/Limits Abbreviation Key ABBREVIATI ON DESCRIPTION PA Prior Authorization Required QL Quantity Limit BvD This drug could be covered as a Part B or a Part D Benefit. ST Step Therapy Required LA Limited Access Drug - Some drugs may be available only at certain pharmacies. For more inform ation consult your pharmacy directory or call Member Services. NM Non-Mail Order Drug - Drugs not eligible for a 90 -day mail order supply through your mail order benefit are noted with \"NM\" under Requirements/Limits. DRUG NAME DRUG 15mg tablet, 300mg-60mg tdwk, 7.5 mcg/hr 20 mcg/hr patch PA, QL (4 EACH PER 28 DAYS) butalb/acetaminophen/caffeine 50-325-40 tablet 2 QL (12 TABS 50mg-325mg tablet, DAY) butalbital/aspirin/caffeine 50-325-40 capsule 2 QL (6 CAPS PER 1 DAY) butalbital/aspirin/caffeine 50-325-40 tablet 2 QL (6 TABS PER 1 DAY) codeine sulfate (15 mg tablet, 30 mg tablet, 60 mg tablet)2 QL (8 TABS PER 1 DAY) ENDOCET (2.5-325 MG TABLET, 5-325 TABLET)2 QL (8 TABS PER 1 DAY) ENDOCET 10-325 MG TABLET 2 QL (5 TABS PER 1 DAY) ENDOCET 7.5-325 MG TABLET 2 QL (7 TABS PER 1 DAY) fentanyl (12 mcg/hr 1 DAY) hydrocodone/ibuprofen 7.5-200 mg tablet 2 QL (8 TABS PER 1 DAY) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 hydromorphone hcl 1 mg/ml liquid 2 QL (20 ML PER 1 DAY) hydromorphone hcl 2 mg tablet 2 QL (8 TABS PER 1 DAY) hydromorphone hcl 4 mg tablet 2 QL (5 TABS PER 1 DAY) hydromorphone hcl 8 mg tablet 2 QL (2 TABS PER 1 DAY) hydromorphone (8 PER 1 DAY) (100 MCG SPRAY, 400 NM LORCET 5-325 MG TABLET 2 QL (8 TABS PER 1 DAY) LORCET HD 10-325 MG TABLET 2 QL (8 TABS PER 1 DAY) LORCET PLUS 7.5-325 MG TABLET 2 QL (8 TABS PER 1 DAY) methadone hcl (5 mg/5 ml solution, 5 mg tablet, 10 mg/5 ml solution, 10 mg/ml oral conc, 10 mg tablet)2 PA METHADONE INTENSOL 10 MG/ML 2 PA morphine sulfate (15 mg tablet er, 30 mg tablet er, 60 mg tablet er)2 PA morphine sulfate 10 mg/5 ml solution 2 QL (45 ML PER 1 DAY) morphine sulfate 100 mg/5ml solution 2 QL (4 ML PER 1 DAY) morphine sulfate 15 mg tablet 2 QL (5 TABS PER 1 DAY) morphine sulfate 20 mg/5 ml solution 2 QL (20 ML PER 1 DAY) morphine sulfate 30 mg tablet 2 QL (2 TABS PER 1 DAY) oxycodone hcl (10mg/0.5ml syringe, 20 mg/ml 1 DAY) oxycodone hcl 10 mg tablet 2 QL (5 TABS PER 1 DAY) oxycodone hcl 15 mg tablet 2 QL (3 TABS PER 1 DAY) oxycodone hcl 20 mg tablet 2 QL (4 TABS PER 1 DAY) oxycodone hcl 5 mg capsule 2 QL (8 CAPS PER 1 DAY) oxycodone hcl 5 mg tablet 2 QL (8 TABS PER 1 DAY) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January NAME DRUG TIERREQUIREMENTS/LIMITS oxycodone hcl 5 mg/5 ml solution 1 DAY) tablet, hcl/acetaminophen 1 DAY) oxycodone hcl/acetaminophen 10mg-325mg tablet 2 QL (5 TABS PER 1 DAY) oxycodone hcl/acetaminophen 7.5-325 mg tablet 2 QL (7 TABS PER 1 DAY) oxycodone hcl/aspirin 4.8355-325 tablet 2 QL (8 TABS PER 1 DAY) TENCON 50-325 MG TABLET 2 QL (12 TABS PER 1 DAY) tramadol hcl 50 mg tablet 1 QL (8 TABS PER 1 DAY) NONSTEROIDAL ANTI-INFLAMMATORY AGENTS celecoxib (50 mg capsule, 100 mg capsule, 200 mg capsule, 400 mg capsule)2 diclofenac potassium 50 mg tablet 2 diclofenac sodium (1 % gel (gram), 3 % gel (gram), 25 mg tablet dr, 50 mg tablet dr, 75 mg tablet dr)2 etodolac (200 mg capsule, 300 mg capsule, 400 mg tab er 24h, 400 mg tablet, 500 mg tab er 24h, 500 mg tablet, 600 mg tab er 24h)2 flurbiprofen (50 mg tablet, 100 mg tablet) 2 IBU (400 MG TABLET, 600 MG TABLET, 800 MG TABLET)1 ibuprofen (400 mg tablet, 600 mg tablet, 800 mg tablet)1 ibuprofen 100 mg/5ml oral susp 2 indomethacin (25 mg capsule, 50 mg capsule) 1 ketorolac tromethamine 10 mg tablet 2 QL (20 TABS PER 30 DAYS) meloxicam (7.5 mg tablet, 15 mg tablet) 1 meloxicam 7.5 mg/5ml oral susp 2 nabumetone (500 mg tablet, 750 mg tablet) 2 naproxen (125 mg/5ml oral susp, 375 mg tablet dr, 500 mg tablet dr)2 naproxen (250 mg tablet, 375 mg tablet, 500 mg tablet)1 piroxicam (10 mg capsule, 20 mg capsule) 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 3DRUG NAME DRUG TIERREQUIREMENTS/LIMITS sulindac (150 mg tablet, 200 mg tablet) 2 ANESTHETICS LOCAL ANESTHETICS GLYDO 2% JELLY SYRINGE 2 lidocaine 5 % adh. patch 2 PA, QL (90 EACH PER 30 DAYS) lidocaine hcl (2 % jelly(ml), 2 % jel/pf app, 2 % jel (ml), 2 % solution, 4 % solution, 40 mg/ml solution)2 lidocaine hcl (g))2 ANTI-ADDICTION/SUBSTANCE ABUSE TREATMENT AGENTS acamprosate calcium 333 mg tablet dr 2 buprenorphine hcl 2 mg tab subl 2 QL (360 TABS PER 30 DAYS) buprenorphine hcl 8 mg tab subl 2 QL (90 TABS DAYS) buprenorphine hcl/naloxone hcl 2 mg-0.5mg tab buprenorphine hcl/naloxone hcl 8 mg-2 mg film 2 QL PER 30 DAYS) buprenorphine hcl/naloxone hcl 8 mg-2 mg tab subl2 QL (90 TABS PER 30 DAYS) bupropion hcl 150 mg tab er 12h 2 CHANTIX (0.5 MG TABLET, 1 MG CONT MONTH BOX, 1 MG TABLET)3 QL (2 TABS PER 1 DAY) CHANTIX STARTING MONTH BOX 3 QL (53 TABS PER 28 DAYS) disulfiram (250 mg tablet, 500 mg tablet) 2 naloxone hcl (0.4 mg/ml vial, 0.4 mg/ml cartridge, hcl 50 mg tablet NARCAN 4 MG NASAL SPRAY 3 NICOTROL CARTRIDGE INHALER 4 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 4DRUG NAME DRUG TIERREQUIREMENTS/LIMITS NICOTROL NS 10 MG/ML SPRAY 4 ANTI-INFECTIVES (SKIN AND MUCOUS MEMBRANE) CLEOCIN 100 MG VAGINAL OVULE 4 clindamycin phosphate 2 % cream/appl 2 metronidazole 0.75 % gel w/appl 2 terconazole (0.4 % cream/appl, % cream/appl, 80 mg supp.vag)2 ANTIANXIETY AGENTS BENZODIAZEPINES alprazolam (0.25 mg tablet, 0.5 mg tablet, 1 mg tablet)1 QL (180 TABS PER 30 DAYS) alprazolam (0.5 mg tab er 24h, 1 mg tab er 24h) 2 QL (6 TABS PER 1 DAY) alprazolam 2 mg tab er 24h 2 QL (5 TABS PER 1 DAY) alprazolam 2 mg tablet 1 QL (150 TABS PER 30 DAYS) alprazolam 3 mg tab er 24h 2 QL (3 TABS PER 1 DAY) buspirone hcl (5 mg tablet, 7.5 mg tablet, 10 mg tablet, 15 mg tablet, 30 mg tablet)2 chlordiazepoxide hcl (5 mg capsule, 10 mg capsule)2 QL (180 CAPS PER 30 DAYS) chlordiazepoxide hcl 25 mg capsule 2 QL (120 CAPS PER 30 DAYS) clobazam 10 mg tablet 2 QL (120 TABS PER 30 DAYS) clobazam 2.5 mg/ml oral susp 2 QL (480 ML PER 30 DAYS) clobazam 20 mg tablet 2 QL (60 TABS PER 30 DAYS) clonazepam (0.125 mg tab rapdis, 0.25 mg tab rapdis, 0.5 mg tab rapdis)2 QL (180 TABS PER 30 DAYS) clonazepam 0.5 mg tablet 1 QL (180 TABS PER 30 DAYS) clonazepam 1 mg tab rapdis 2 QL (120 TABS PER 30 DAYS) clonazepam 1 mg tablet 1 QL (120 TABS PER 30 DAYS) clonazepam 2 mg tab rapdis 2 QL (300 TABS PER 30 DAYS) clonazepam 2 mg tablet 1 QL (300 TABS PER 30 DAYS) clorazepate dipotassium (3.75 mg tablet, 7.5 mg tablet, 15 mg tablet)2 QL (180 TABS PER 30 DAYS) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 5DRUG NAME DRUG TIERREQUIREMENTS/LIMITS DIASTAT 2.5 MG PEDI SYSTEM 4 QL (40 EACH PER 30 DAYS) DIASTAT ACUDIAL 12.5-15-20 MG 4 QL (40 EACH DIASTAT ACUDIAL 5-7.5-10 MG KT 4 QL (20 EACH PER 30 DAYS) diazepam (2 mg tablet, 5 mg tablet) 1 QL (180 TABS PER 30 DAYS) diazepam 10 mg tablet 1 QL (120 TABS PER 30 DAYS) diazepam 5 mg/5 ml solution 2 QL (1200 ML PER 30 DAYS) diazepam 5 mg/ml oral conc 2 QL (240 ML PER 30 DAYS) lorazepam (0.5 mg tablet, 1 mg tablet, 2 mg tablet)1 QL (180 TABS PER 30 DAYS) lorazepam 2 mg/ml oral conc 2 QL (150 ML PER 30 DAYS) LORAZEPAM INTENSOL 2 MG/ML 2 QL (150 ML PER 30 DAYS) SYMPAZAN (5 MG FILM, 10 MG FILM, 20 MG FILM)4 temazepam (15 mg capsule, 30 mg capsule) 2 QL (30 CAPS PER 30 DAYS) ANTIBACTERIALS AMINOGLYCOSIDES amikacin MG/4 ML AMPULE (224 ML PER 30 DAYS), NM, BvsD gentamicin sulfate (20 mg/2 ml in port, sulfate/pf 100mg/10ml vial port)2 neomycin sulfate 500 mg tablet 1 streptomycin sulfate 1 g vial 2 TOBI PODHALER 28 MG INHALE CAP 5 PA, QL (224 EACH PER 30 DAYS), NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 30 DAYS), NM, BvsD tobramycin sulfate (1.2 g vial, 10 vial)2 PA tobramycin/nebulizer 300 mg/5ml ampul-neb PA, PER 30 DAYS), NM ANTIBACTERIALS, MISCELLANEOUS clindamycin hcl (75 mg capsule, 150 palmitate hcl mg/ml vial, 300 mg/2ml 600 mg/4ml vial port, 900mg/6ml vial port)2 colistin (colistimethate na) 150 mg vial 5 PA, NM daptomycin (350 mg vial, 500 mg vial) 5 PA, NM FIRVANQ (25 METRO IV 500 MG/100 ML 2 metronidazole (250 mg tablet, 500 mg tablet) 2 metronidazole/sodium chloride piggyback2 MONUROL susp, 50 mg capsule)2 nitrofurantoin macrocrystal (25 mg capsule, 50 mg capsule, 100 mg capsule)2 nitrofurantoin monohyd/m-cryst 100 mg capsule 2 polymyxin b sulfate 500k unit vial 2 SIVEXTRO (200 MG TABLET, 200 MG VIAL)5 PA, NM trimethoprim 100 mg tablet 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 7DRUG NAME DRUG TIERREQUIREMENTS/LIMITS vancomycin hcl (1 g vial, 1 g vial port, 1.25 g vial, 1.5 g vial, 5 g vial, 10 g vial, 100 g bulkbaginj, 125 mg capsule, 250 mg capsule, 250 mg vial, 500 mg vial port, 500 mg vial, 750 mg vial, 750 mg vial port)2 XIFAXAN (200 MG TABLET, 550 1 g tablet 1 cefazolin sodium (1 g vial port, 1 g vial, 10 g vial, 20 g vial, 100 g bulkbaginj, 300g 2 g vial) 2 cefepime hcl in dextrose 5 % in water (in 5 % 1 g/50 ml piggyback, in 5 % 2 g/50 g/100 ml froz.piggy)2 cefixime 400 mg capsule 2 cefoxitin sodium (1 g vial, 2 g vial) 2 cefoxitin iso-osmotic recon, recon, 500 mg tablet)2 ceftazidime (1 g vial, 2 g vial, 6 g vial) 2 ceftazidime in dextrose 5% and water (in 1 g/50 ml piggyback, in 2 g/50 ml piggyback)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 8DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ceftriaxone sodium (1 g vial, 1 g pggybk btl, 1 g vial port, 2 g vial port, 2 g pggybk btl, 2 g vial, 10 g vial, 100 g bulkbaginj, 250 mg vial, 500 mg vial)2 ceftriaxone sodium in iso-osmotic dextrose (in 1 g/50 1 g/50 piggyback, in in 2 g/50 ml froz.piggy)2 cefuroxime axetil (250 mg tablet, 500 mg tablet) 2 cefuroxime sodium (1.5 g vial, 750 mg vial) 2 mg/5ml susp recon, 250 mg/5ml susp mg capsule, 500 mg capsule) 1 SUPRAX 400 MG CAPSULE 4 TEFLARO (400 MG VIAL, 600 MG VIAL) 5 vial port, 500 mg vial, 600 mg tablet)2 azithromycin (250 mg tablet, 500 mg tablet) 1 clarithromycin (125 mg/5ml susp recon, 250 recon, PA, NM ERYTHROCIN 500 MG VIAL, 500 MG ADDVAN VIAL)4 erythromycin base 250 mg capsule dr 2 MISCELLANEOUS B-LACTAM ANTIBIOTICS aztreonam (1 g vial, 2 g vial) 5 NM CAYSTON 75 MG INHAL SOLUTION 5 PA, LA, QL (84 ML PER 30 DAYS), NM ertapenem sodium 1 g vial 5 NM imipenem/cilastatin sodium (imipenem/cilastatin 250 mg vial, imipenem/cilastatin 500 mg vial)2 meropenem (1 g vial, 500 mg vial) 2 meropenem in 0.9 % sodium chloride (1 g/50 ml piggyback, 500mg/50ml piggyback)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January PENICILLINS amoxicillin mg/5ml susp recon)2 amoxicillin (250 mg capsule, 500 mg tablet, ampicillin sodium (1 g vial port, 1 g vial, 2 g vial, 2 g vial port, 10 g vial, 125 mg vial, 250 mg vial, 500 mg vial)2 ampicillin sodium/sulbactam sodium (sodium/sulbactam 1.5 g vial, sodium/sulbactam 1.5 g vial port, sodium/sulbactam 3 g vial, sodium/sulbactam 3 g vial port, sodium/sulbactam 15 g vial)2 ampicillin trihydrate (250 mg capsule, (1.2 MILLION UNIT, 900-300 SYRINGE)3 dicloxacillin capsule, 500 mg in dextrose, iso-osmotic (in 2 g/100 ml froz.piggy)2 nafcillin sodium (1 g vial port, 1 g vial, 2 g vial, 2 g vial port)2 nafcillin sodium 10 g vial 5 NM penicillin g potassium (g 5mm unit vial, g 20mm unit vial)2 penicillin g potassium/dextrose-water tablet, 250 mg/5ml soln recon, 500 mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January NAME DRUG TIERREQUIREMENTS/LIMITS piperacillin sodium/tazobactam sodium (sodium/tazobactam 2.25 g vial port, g vial, sodium/tazobactam 3.375 g vial, sodium/tazobactam 3.375 g vial port, sodium/tazobactam 4.5 g vial, sodium/tazobactam 4.5 g vial port, sodium/tazobactam 13.5 g vial, sodium/tazobactam 40.5 g vial)2 QUINOLONES rec)2 ciprofloxacin hcl (100 mg tablet, 250 mg tablet, 500 mg tablet, 750 mg tablet)1 ciprofloxacin lactate/dextrose 5 % in water (in 5 250 mg tablet, 500mg/20ml solution, 500 mg tablet, 750 mg tablet)2 moxifloxacin hcl 400 mg tablet 2 SULFONAMIDES (150 mg 300 mg tablet)2 DOXY 100 VIAL 2 doxycycline hyclate (20 mg tablet, 50 mg capsule, 100 mg tablet, 100 mg capsule)2 doxycycline monohydrate (50 mg tablet, 50 mg capsule, 100 mg capsule, 100 mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 11DRUG NAME DRUG TIERREQUIREMENTS/LIMITS minocycline hcl (50 mg capsule, 75 mg capsule, 100 mg capsule)2 NUZYRA (150 MG TABLET-7 DAY, 150 MG TABLET, 150 MG-7 DAY WITH LOAD)5 PA, NM tetracycline hcl (250 mg capsule, 500 mg capsule) 2 tigecycline 50 mg vial 5 NM ANTICANCER AGENTS abiraterone acetate 250 mg tablet 5 PA - FOR NEW STARTS ONLY, NM AFINITOR (2.5 MG TABLET, 5 MG TABLET, 7.5 MG TABLET, 10 MG TABLET)5 NM AFINITOR DISPERZ (2 MG TABLET, 3 MG TABLET, 5 MG TABLET)5 NM ALECENSA 150 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM ALUNBRIG (30 MG TABLET, 90 MG-180 MG TAB PACK, 90 MG TABLET, 180 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM anastrozole 1 mg tablet 1 BALVERSA (3 MG TABLET, 4 MG TABLET, 5 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM bexarotene 75 mg capsule 5 NM bicalutamide 50 mg tablet 2 BOSULIF (100 MG TABLET, 400 MG TABLET, 500 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM BRAFTOVI (50 MG CAPSULE, 75 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM CABOMETYX (20 MG TABLET, 40 MG TABLET, 60 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM CALQUENCE 100 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM CAPRELSA (100 MG TABLET, 300 MG TABLET)5 LA, NM COMETRIQ (60 MG PACK, 100 MG PK, 140 MG PK)5 PA - FOR NEW STARTS ONLY, LA, NM COPIKTRA (15 MG CAPSULE, 25 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 12DRUG NAME DRUG TIERREQUIREMENTS/LIMITS COTELLIC 20 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM cyclophosphamide (25 mg capsule, 50 mg capsule)2 PA - Part B vs D Determination DAURISMO (25 MG TABLET, 100 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM EMCYT 140 MG CAPSULE 3 ERIVEDGE 150 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, LA, NM ERLEADA 60 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM erlotinib hcl (25 mg tablet, 100 mg tablet, 150 mg tablet)5 NM exemestane 25 mg tablet 2 FARYDAK (10 MG CAPSULE, 15 MG CAPSULE, 20 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM FIRMAGON (2 X 120 MG KIT, 2 X 120 MG VIALS, 80 MG KIT, 80 MG VIAL, 120 MG VIAL)4 flutamide 125 mg capsule 2 fulvestrant 250 mg/5ml syringe 5 PA - FOR NEW STARTS ONLY, NM GILOTRIF (20 MG TABLET, 30 MG TABLET, 40 MG TABLET)5 PA - FOR NEW STARTS ONLY, LA, NM GLEOSTINE (5 MG CAPSULE, 10 MG CAPSULE, 40 MG CAPSULE)3 GLEOSTINE 100 MG CAPSULE 5 NM hydroxyurea 500 mg capsule 2 IBRANCE (75 MG CAPSULE, 100 MG CAPSULE, 125 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM ICLUSIG (15 MG TABLET, 45 MG TABLET) 5 PA - FOR NEW STARTS ONLY, LA, NM IDHIFA (50 MG TABLET, 100 MG TABLET) 5 PA - FOR NEW STARTS ONLY, NM imatinib mesylate (100 mg tablet, 400 mg tablet) 5 NM IMBRUVICA (70 MG CAPSULE, 140 MG TABLET, 140 MG CAPSULE, 280 MG TABLET, 420 MG TABLET, 560 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 13DRUG NAME DRUG TIERREQUIREMENTS/LIMITS INLYTA (1 MG TABLET, 5 MG TABLET) 5 PA - FOR NEW STARTS ONLY, LA, NM INREBIC 100 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM IRESSA 250 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM JAKAFI (5 MG TABLET, 10 MG TABLET, 15 MG TABLET, 20 MG TABLET, 25 MG TABLET)5 PA - FOR NEW STARTS ONLY, LA, NM KANJINTI 420 MG VIAL 5 PA - FOR NEW STARTS ONLY, NM KISQALI (200 MG DAILY, 400 MG DAILY, 600 MG DAILY)5 PA - FOR NEW STARTS ONLY, NM KISQALI FEMARA CO-PACK (200 MG, 400 MG, 600 MG)5 PA - FOR NEW STARTS ONLY, NM LENVIMA (4 MG CAPSULE, 8 MG DAILY DOSE, 10 MG DAILY DOSE, 12 MG DAILY DOSE, 14 MG DAILY DOSE, 18 MG DAILY DOSE, 20 MG DAILY DOSE, 24 MG DAILY DOSE)5 PA - FOR NEW STARTS ONLY, LA, NM letrozole 2.5 mg tablet 1 LEUKERAN 2 MG TABLET 5 NM leuprolide acetate (1 mg/0.2ml vial, 1 mg/0.2ml MG-6.14 MG TABLET, 20 MG-8.19 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM LORBRENA (25 MG TABLET, 100 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM LUPRON DEPOT (DEPOT 3.75 MG KIT, DEPOT-4 MONTH KIT, DEPOT 7.5 MG KIT, DEPOT 11.25 MG 3MO KIT, DEPOT 22.5 MG 3MO KIT, DEPOT 45 MG 6MO KIT)5 PA - FOR NEW STARTS ONLY, (LUPANETA) (DEPO 11.25MG (LUPANETA), DEPOT FOR NEW STARTS ONLY, NM LUPRON DEPOT-PED (7.5 MG KIT, 11.25 MG 3MO)5 PA - FOR NEW STARTS ONLY, NM LYNPARZA (100 MG TABLET, 150 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 14DRUG NAME DRUG TIERREQUIREMENTS/LIMITS LYSODREN 500 MG TABLET 5 NM MATULANE 50 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, LA, NM megestrol acetate (20 mg tablet, 40 mg tablet) 2 MEKINIST (0.5 MG TABLET, 2 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM MEKTOVI 15 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM mercaptopurine 50 mg tablet 2 methotrexate sodium (2.5 mg tablet, 25 mg/ml vial)2 PA - Part B vs D Determination methotrexate sodium/pf 25 mg/ml vial 1 PA - Part B vs D Determination MVASI (100 MG/4 ML VIAL, 400 MG/16 ML VIAL)5 PA - FOR NEW STARTS ONLY, NM NERLYNX 40 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM NEXAVAR 200 MG TABLET 5 LA, NM nilutamide 150 mg tablet 5 NM NINLARO (2.3 MG CAPSULE, 3 MG CAPSULE, 4 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM NUBEQA 300 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM ODOMZO 200 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM PIQRAY (200 MG DAILY, 250 MG DAILY, 300 MG DAILY)5 PA - FOR NEW STARTS ONLY, NM POLIVY 140 MG VIAL 5 PA - FOR NEW STARTS ONLY, NM POMALYST (1 MG CAPSULE, 2 MG CAPSULE, 3 MG CAPSULE, 4 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, LA, NM PURIXAN 20 MG/ML ORAL SUSP 4 REVLIMID (2.5 MG CAPSULE, 5 MG CAPSULE, 10 MG CAPSULE, 15 MG CAPSULE, 20 MG CAPSULE, 25 MG CAPSULE)5 LA, NM ROZLYTREK (100 MG CAPSULE, 200 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 15DRUG NAME DRUG TIERREQUIREMENTS/LIMITS RUBRACA (200 MG TABLET, 250 MG TABLET, 300 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM RYDAPT 25 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM SOLTAMOX (10 MG/5 ML SOLN, 20 MG/10 ML SOLN)4 SPRYCEL (20 MG TABLET, 50 MG TABLET, 70 MG TABLET, 80 MG TABLET, 100 MG TABLET, 140 MG TABLET)5 NM STIVARGA 40 MG TABLET 5 PA - FOR NEW STARTS ONLY, LA, NM SUTENT (12.5 MG CAPSULE, 25 MG CAPSULE, 37.5 MG CAPSULE, 50 MG CAPSULE)5 NM SYNRIBO 3.5 MG/ML VIAL 5 PA - FOR NEW STARTS ONLY, NM TABLOID 40 MG TABLET 3 TAFINLAR (50 MG CAPSULE, 75 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM TAGRISSO (40 MG TABLET, 80 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM TALZENNA (0.25 MG CAPSULE, 1 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM tamoxifen citrate (10 mg tablet, 20 mg tablet) 2 TARGRETIN 1% GEL 5 PA - FOR NEW STARTS ONLY, NM TASIGNA (50 MG CAPSULE, 150 MG CAPSULE, 200 MG CAPSULE)5 NM TIBSOVO 250 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM toremifene citrate 60 mg tablet 5 NM TRELSTAR (3.75 MG VIAL, 11.25 MG VIAL, 22.5 MG VIAL)5 PA - FOR NEW STARTS ONLY, NM tretinoin 10 mg capsule 5 NM TURALIO 200 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM TYKERB 250 MG TABLET 5 LA, NM VENCLEXTA (50 MG TABLET, 100 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 16DRUG NAME DRUG TIERREQUIREMENTS/LIMITS VENCLEXTA 10 MG TABLET 4 PA - FOR NEW STARTS ONLY VENCLEXTA STARTING PACK 5 PA - FOR NEW STARTS ONLY, NM VERZENIO (50 MG TABLET, 100 MG TABLET, 150 MG TABLET, 200 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM VITRAKVI (20 MG/ML SOLUTION, 25 MG CAPSULE, 100 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM VIZIMPRO (15 MG TABLET, 30 MG TABLET, 45 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM VOTRIENT 200 MG TABLET 5 NM XALKORI (200 MG CAPSULE, 250 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, LA, NM XATMEP 2.5 MG/ML ORAL SOLUTION 4 PA - FOR NEW STARTS ONLY, BvsD XOSPATA 40 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM XPOVIO (60 MG ONCE, 80 MG ONCE, 80 MG TWICE, 100 MG ONCE)5 PA - FOR NEW STARTS ONLY, NM XTANDI 40 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, LA, NM YONSA 125 MG TABLET 5 PA - FOR NEW STARTS ONLY, NM ZEJULA 100 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM ZELBORAF 240 MG TABLET 5 PA - FOR NEW STARTS ONLY, LA, NM ZOLINZA 100 MG CAPSULE 5 PA - FOR NEW STARTS ONLY, NM ZYDELIG (100 MG TABLET, 150 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM ZYKADIA (150 MG CAPSULE, 150 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM ZYTIGA 500 MG TABLET 5 PA - FOR NEW STARTS ONLY, LA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January DRUG TIERREQUIREMENTS/LIMITS ANTICHOLINERGIC propantheline bromide 15 mg tablet 2 ANTICONVULSANTS APTIOM (200 MG TABLET, 400 MG TABLET, 600 MG TABLET, 800 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM BANZEL 200 MG TABLET 5 PA - FOR NEW STARTS ONLY, QL (16 TABS PER 1 DAY), NM BANZEL 40 MG/ML SUSPENSION 5 PA - FOR NEW STARTS ONLY, QL (80 ML PER 1 DAY), NM BANZEL 400 MG TABLET 5 PA - FOR NEW STARTS ONLY, QL (8 TABS PER 1 DAY), NM BRIVIACT (10 MG TABLET, 25 MG TABLET, 50 MG TABLET, 75 MG TABLET, 100 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM BRIVIACT 10 MG/ML ORAL SOLN 4 PA - FOR NEW STARTS ONLY carbamazepine (100 mg tab er 12h, 100 mg/5ml oral susp, 100 mg cpmp 12hr, 100 mg tab chew, 200 mg tab er 12h, 200 mg tablet, 200 mg cpmp 12hr, 300 mg cpmp 12hr, 400 mg tab er 12h)2 CELONTIN 300 MG KAPSEAL 4 diazepam (2.5 mg kit, 12.5-15-20 kit) 2 QL (40 EACH PER 30 DAYS) diazepam 5-7.5-10mg kit 2 QL (20 EACH PER 30 DAYS) DILANTIN 30 MG CAPSULE 3 divalproex sodium (125 mg tablet dr, 125 mg cap dr spr, 250 mg tablet dr, 250 mg tab er 24h, 500 mg tab er 24h, 500 mg tablet dr)2 EPIDIOLEX 100 MG/ML SOLUTION 5 PA - FOR NEW STARTS ONLY, NM EPITOL 200 MG TABLET 2 ethosuximide (250 mg/5ml solution, 250 mg capsule)2 felbamate (400 mg tablet, 600 mg tablet) 2 felbamate 600 mg/5ml oral susp 5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, NAME DRUG TIERREQUIREMENTS/LIMITS FYCOMPA (0.5 MG/ML ORAL SUSP, 2 MG TABLET, 4 MG TABLET, 6 MG TABLET, 8 MG TABLET, 10 MG TABLET, 12 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM gabapentin (100 mg capsule, 300 mg capsule) 2 QL (12 CAPS PER 1 DAY) gabapentin (250 mg/5ml solution, 300 mg/6ml solution)2 QL (72 ML PER 1 DAY) gabapentin 400 mg capsule 2 QL (9 CAPS PER 1 DAY) gabapentin 600 mg tablet 2 QL (6 TABS PER 1 DAY) gabapentin 800 mg tablet 2 QL (4 TABS PER 1 DAY) lamotrigine (5 mg tb chw dsp, 25 mg tab rapdis, 25 mg tb chw dsp, 25 mg tablet, 50 mg tab rapdis, 100 mg tablet, 100 mg tab rapdis, 150 mg tablet, 200 mg tablet, 200 mg tab rapdis)2 levetiracetam (100 mg/ml solution, 250 mg tablet, 500 mg tab er 24h, 500 mg tablet, 500 mg/5ml solution, 750 mg tablet, 750 mg tab er 24h, 1000 mg tablet)2 LYRICA (225 MG CAPSULE, 300 MG CAPSULE)3 QL (2 CAPS PER 1 DAY) LYRICA (25 MG CAPSULE, 50 MG CAPSULE, 75 MG CAPSULE, 100 MG CAPSULE, 150 MG CAPSULE, 200 MG CAPSULE)3 QL (3 CAPS PER 1 DAY) LYRICA 20 MG/ML ORAL SOLUTION 3 QL (30 ML PER 1 DAY) oxcarbazepine (150 mg tablet, 300 mg/5ml oral susp, 300 mg tablet, 600 mg tablet)2 PEGANONE 250 MG TABLET 4 phenobarbital (15 mg tablet, 16.2 mg tablet, 20 mg/5 ml elixir, 30 mg tablet, 32.4 mg tablet, 60 mg tablet, 64.8 mg tablet, 97.2mg tablet, 100 mg tablet)2 phenytoin (50 mg tab chew, 100 mg/4ml oral susp, 125 mg/5ml oral susp)2 phenytoin sodium extended (100 mg capsule, 200 mg capsule, 300 mg capsule)2 pregabalin (225 mg capsule, 300 mg capsule) 2 QL (2 CAPS PER 1 DAY) pregabalin (25 mg capsule, 50 mg capsule, 75 mg capsule, 100 mg capsule, 150 mg capsule, 200 mg capsule)2 QL (3 CAPS PER 1 DAY) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 NAME DRUG TIERREQUIREMENTS/LIMITS pregabalin 20 mg/ml solution 2 QL (30 ML PER 1 DAY) primidone (50 mg tablet, 250 mg tablet) 2 SPRITAM (250 MG TABLET, 500 MG TABLET, 750 MG TABLET, 1,000 MG TABLET)4 PA - FOR NEW STARTS ONLY SUBVENITE (25 MG TABLET, 100 MG TABLET, 150 MG TABLET, 200 MG TABLET)2 tiagabine hcl (2 mg tablet, 4 mg tablet, 12 mg tablet, 16 mg tablet)2 topiramate (15 mg cap sprink, 25 mg cap sprink, 25 mg tablet, 50 mg tablet, 100 mg tablet, 200 mg tablet)2 valproic acid (as sodium salt) (valproate sodium) (salt) 250 mg/5ml solution, salt) 500mg/10ml solution)2 valproic acid 250 mg capsule 2 vigabatrin (500 mg tablet, 500 mg powd pack) 5 PA - FOR NEW STARTS ONLY, LA, NM VIGADRONE 500 MG POWDER PACKET 5 PA - FOR NEW STARTS ONLY, LA, NM VIMPAT (150 MG TABLET, 200 MG TABLET)3 QL (2 TABS PER 1 DAY) VIMPAT 10 MG/ML SOLUTION 3 QL (40 ML PER 1 DAY) VIMPAT 100 MG TABLET 3 QL (4 TABS PER 1 DAY) VIMPAT 200 MG/20 ML VIAL 3 VIMPAT 50 MG TABLET 3 QL (8 TABS PER 1 DAY) zonisamide (25 mg capsule, 50 mg capsule, 100 mg capsule)2 ANTIDEMENTIA AGENTS donepezil hcl (5 mg tablet, 5 mg tab rapdis, 10 mg tablet, 10 mg tab rapdis)2 galantamine hbr (4 mg/ml solution, 4 mg tablet, 8 mg cap24h pel, 8 mg tablet, 12 mg tablet, 16 mg cap24h pel, 24 mg cap24h pel)2 memantine hcl (2 mg/ml solution, 5 mg tablet, 5 mg-10 mg tab ds pk, 10 mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January tartrate (1.5 mg capsule, 3 mg capsule, 4.5 mg capsule, 6 mg capsule)2 ANTIDEPRESSANTS amitriptyline hcl (10 mg tablet, 25 mg tablet, 50 mg tablet, 75 mg tablet, 100 mg tablet, 150 mg tablet)2 PA - FOR NEW STARTS ONLY amoxapine (25 mg tablet, 50 mg tablet, 100 mg tablet, 150 mg tablet)2 bupropion hcl (75 mg tablet, 100 mg tab er 12h, 100 mg tab sr 12h, 100 mg tablet, 100 mg tablet er, 150 mg tab er 24h, 150 mg tab er 12h, 150 mg tablet er, 150 mg tab sr 12h, 200 mg tab sr 12h, 200 mg tablet er, 200 mg tab er 12h, 300 mg tab er 24h)2 citalopram hydrobromide (10 mg tablet, 20 mg tablet, 40 mg tablet)1 citalopram hydrobromide (10 mg/5 ml solution, 20 mg/10ml solution)2 clomipramine hcl (25 mg capsule, 50 mg capsule, 75 mg capsule)2 PA - FOR NEW STARTS ONLY desipramine hcl (10 mg tablet, 25 mg tablet, 50 mg tablet, 75 mg tablet, 100 mg tablet, 150 mg tablet)2 desvenlafaxine suc er 100 mg tablet (generic for pristiq)2 PA - FOR NEW STARTS ONLY desvenlafaxine suc er 25 mg tablet (generic for pristiq)2 PA - FOR NEW STARTS ONLY desvenlafaxine suc er 50 mg tablet (generic for pristiq)2 PA - FOR NEW STARTS ONLY doxepin hcl (10 mg capsule, 25 mg capsule, 50 mg capsule, 75 mg capsule, 100 mg capsule, 150 mg capsule)2 PA - FOR NEW STARTS ONLY doxepin hcl 10 mg/ml oral conc 1 PA - FOR NEW STARTS ONLY duloxetine hcl (20 mg capsule dr, 30 mg capsule dr, 60 mg capsule dr)2 EMSAM (6 MG/24 PATCH, 9 MG/24 PATCH, 12 MG/24 PATCH)5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 21DRUG NAME DRUG TIERREQUIREMENTS/LIMITS escitalopram oxalate (5 mg tablet, 10 mg tablet, 20 mg tablet)1 escitalopram oxalate 5 mg/5 ml solution 2 FETZIMA (ER 20 MG CAPSULE, 20-40 MG TITRATION PAK, ER 40 MG CAPSULE, ER 80 MG CAPSULE, ER 120 MG CAPSULE)4 PA - FOR NEW STARTS ONLY fluoxetine hcl (10 mg capsule, 20 mg capsule, 40 mg capsule)1 fluoxetine hcl 20 mg/5 ml solution 2 fluvoxamine maleate (25 mg tablet, 50 mg tablet, 100 mg tablet)2 imipramine hcl (10 mg tablet, 25 mg tablet, 50 mg tablet)2 PA - FOR NEW STARTS ONLY maprotiline hcl (25 mg tablet, 50 mg tablet, 75 mg tablet)2 MARPLAN 10 MG TABLET 4 mirtazapine (7.5 mg tablet, 15 mg tab rapdis, 15 mg tablet, 30 mg tablet, 30 mg tab rapdis, 45 mg tablet, 45 mg tab rapdis)2 nefazodone hcl (50 mg tablet, 100 mg tablet, 150 mg tablet, 200 mg tablet, 250 mg tablet)2 nortriptyline hcl (10 mg capsule, 25 mg capsule, 50 mg capsule, 75 mg capsule)1 nortriptyline hcl (10 mg/5 ml solution, 20 mg/10ml solution)2 paroxetine hcl (10 mg tablet, 20 mg tablet, 30 mg tablet, 40 mg tablet)1 PAXIL 10 MG/5 ML SUSPENSION 4 phenelzine sulfate 15 mg tablet 2 protriptyline hcl (5 mg tablet, 10 mg tablet) 2 sertraline hcl (25 mg tablet, 50 mg tablet, 100 mg tablet)1 sertraline hcl 20 mg/ml oral conc 2 SPRAVATO (28 MG NASAL SPRAY, 56 MG DOSE PACK, 84 MG DOSE PACK)5 PA - FOR NEW STARTS ONLY, NM tranylcypromine sulfate 10 mg tablet 2 trazodone hcl (50 mg tablet, 100 mg tablet, 150 mg tablet, 300 mg tablet)1 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 22DRUG NAME DRUG TIERREQUIREMENTS/LIMITS trimipramine maleate (25 mg capsule, 50 mg capsule, 100 mg capsule)2 PA - FOR NEW STARTS ONLY TRINTELLIX (5 MG TABLET, 10 MG TABLET, 20 MG TABLET)4 PA - FOR NEW STARTS ONLY venlafaxine hcl (25 mg tablet, 37.5 mg cap er 24h, 37.5 mg tablet, 50 mg tablet, 75 mg cap er 24h, 75 mg tablet, 100 mg tablet, 150 mg cap er 24h)2 VIIBRYD (10 MG TABLET, 10-20 MG STARTER PACK, 20 MG TABLET, 40 MG TABLET)4 PA - FOR NEW STARTS ONLY ZULRESSO 100 MG/20 ML VIAL 5 PA - FOR NEW STARTS ONLY, NM ANTIDIABETIC AGENTS ANTIDIABETIC AGENTS, MISCELLANEOUS acarbose (25 mg tablet, 50 mg tablet, 100 mg tablet)2 BYDUREON 2 MG PEN INJECT 3 QL (4 EACH PER 28 DAYS) BYDUREON BCISE 2 MG AUTOINJECT 3 QL (3.4 ML PER 28 DAYS) BYETTA 10 MCG DOSE PEN INJ 3 QL (2.4 ML PER 30 DAYS) BYETTA 5 MCG DOSE PEN INJ 3 QL (1.2 ML PER 30 DAYS) GLUCAGEN (1 MG, 1 MG 2-PACK) 3 GLUCAGON 1 MG EMERGENCY KIT 3 INVOKAMET (50-1,000 MG TABLET, 50-500 MG TABLET, 150-1,000 MG TABLET, 150- 500 MG TABLET)3 QL (60 TABS PER 30 DAYS) INVOKAMET XR (50-1,000 MG TAB, 50-500 MG TABLET, 150-500 MG TABLET, 150- 1,000 MG TAB)3 QL (60 TABS PER 30 DAYS) INVOKANA (100 MG TABLET, 300 MG TABLET)3 JARDIANCE (10 MG TABLET, 25 MG TABLET)3 JENTADUETO (2.5 MG-500 MG TAB, 2.5 MG-850 MG TAB, 2.5 MG-1000 MG TAB)3 QL (60 TABS PER 30 DAYS) JENTADUETO XR 2.5 MG-1,000 MG 3 QL (60 TABS PER DAYS) JENTADUETO XR 5 MG-1,000 MG TB 3 QL (30 TABS PER 30 DAYS) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 23DRUG NAME DRUG TIERREQUIREMENTS/LIMITS KORLYM 300 MG TABLET 5 PA, NM metformin hcl 1,000 mg tablet (generic for glucophage)1 QL (75 TABS PER 30 DAYS) metformin hcl 500 mg tab er 24h 1 QL (120 TABS PER 30 DAYS) metformin hcl 500 mg tablet (generic for glucophage)1 QL (150 TABS PER 30 DAYS) metformin hcl 750 mg tab er 24h 1 QL (60 TABS PER 30 DAYS) metformin hcl 850 mg tablet 1 QL (90 TABS PER 30 DAYS) miglitol (25 mg tablet, 50 mg tablet, 100 mg tablet)2 nateglinide (60 mg tablet, 120 mg tablet) 2 OZEMPIC 0.25-0.5 MG DOSE PEN 3 QL (1.5 ML PER 28 DAYS) OZEMPIC 1 MG DOSE PEN 3 QL (3 ML PER 28 DAYS) pioglitazone hcl (30 mg tablet, 45 mg tablet) 1 QL (30 TABS PER 30 DAYS) pioglitazone hcl 15 mg tablet 1 QL (90 TABS PER 30 DAYS) pioglitazone hcl/glimepiride (hcl/glimepiride mg tablet, hcl/glimepiride 30 PER 30 DAYS) repaglinide (0.5 mg tablet, 1 mg tablet, 2 mg tablet)2 SYMLINPEN 120 PEN INJECTOR MG TABLET, QL (60 TABS PER 30 DAYS) SYNJARDY 5-500 MG TABLET 3 QL (120 TABS PER 30 DAYS) SYNJARDY XR (10-1,000 MG TABLET, 25- 1,000 MG PER 30 DAYS) XR (5-1,000 MG TABLET, 12.5- 1,000 MG TAB)3 QL (60 TABS PER 30 DAYS) TRADJENTA 5 MG TABLET 3 TRULICITY (0.75 MG/0.5 ML PEN, 1.5 MG/0.5 ML PEN)3 QL (2 ML PER 28 DAYS) VICTOZA 2-PAK 18 MG/3 ML PEN 3 QL (9 ML PER 30 DAYS) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January NAME DRUG TIERREQUIREMENTS/LIMITS VICTOZA 3-PAK 18 MG/3 ML PEN 3 QL (9 ML PER 30 DAYS) INSULINS HUMALOG (100 UNIT/ML 100 KWIKPEN 3 MIX VIAL 3 HUMULIN R 500 UNITS/ML KWIKPEN 5 NM HUMULIN R 500 insuln glimepiride 1 mg tablet 1 QL (240 TABS PER 30 DAYS) glimepiride 2 mg tablet 1 QL (120 TABS PER 30 DAYS) glimepiride 4 mg tablet 1 QL (60 TABS PER 30 DAYS) glipizide 10 mg tab er 24 2 QL (60 TABS PER 30 DAYS) glipizide 10 mg tablet 1 QL (120 TABS PER 30 DAYS) glipizide 2.5 mg tab er 24 2 QL (240 TABS PER 30 DAYS) glipizide 5 mg tab er 24 2 QL (120 TABS PER 30 DAYS) glipizide 5 mg tablet 1 QL (240 TABS PER 30 DAYS) glipizide/metformin hcl mg tablet, glipizide/metformin TABS PER 30 DAYS) glipizide/metformin hcl 2.5-250 mg tablet 2 QL (240 TABS PER 30 DAYS) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January NAME DRUG TIERREQUIREMENTS/LIMITS ANTIFUNGALS MG/20 ML VIAL 5 PA, 50 MG VIAL 5 PA, NM, BvsD amphotericin b 50 mg vial 2 PA, BvsD caspofungin acetate (50 mg vial, 70 mg vial) 5 PA, NM ciclopirox (0.77 % gel (gram), 8 % solution) 2 olamine (0.77 % cream (g), 0.77 % 2 clotrimazole/betamethasone dip 1 %-0.05 % cream (g)2 CRESEMBA 186 MG CAPSULE 5 PA, NM ERAXIS(WATER DIL) 100 MG VIAL 5 PA, NM ERAXIS(WATER DIL) 50 MG VIAL 4 (50 mg tablet, 100 mg tablet, 150 mg tablet, 200 mg tablet)1 fluconazole mg capsule) 5 NM griseofulvin ultramicrosize (125 mg tablet, 250 mg oral susp, 500 mg tablet)2 (10 mg/ml solution, 100 mg capsule) 2 PA ketoconazole (2 % cream (g), 2 % shampoo, 200 mg tablet)2 NOXAFIL (40 MG/ML SUSPENSION, DR 100 MG TABLET)5 PA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 DRUG 100,000 UNITS/GM POWDER mg tablet dr 5 PA, NM terbinafine hcl 250 mg tablet 1 voriconazole (200 mg vial, 200 mg tablet) 2 PA voriconazole (50 mg tablet, 200 mg/5ml susp recon)5 PA, NM ANTIGOUT AGENTS ANTIGOUT AGENTS, OTHER allopurinol (100 mg tablet, 300 mg tablet) 1 colchicine (0.6 mg capsule, 0.6 mg tablet) 2 febuxostat (40 mg tablet, 80 mg tablet) 2 ST probenecid 500 mg tablet 2 probenecid/colchicine 500-0.5 mg tablet 2 ULORIC (40 MG TABLET, 80 MG TABLET) 3 ST ANTIHISTAMINES cetirizine hcl 1 mg/ml solution 1 cyproheptadine hcl (2 4 ml syrup, tablet)2 diphenhydramine hcl 50 mg/ml vial 1 hydroxyzine hcl (10 mg tablet, 10 mg/5 ml solution, 25 mg tablet, 50 mg/25ml solution, 50 mg tablet)2 levocetirizine DOSE-2 AUTOINJ 4 PA, QL (2 ML PER 30 DAYS) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January AIMOVIG AUTOINJECTOR (70 MG/ML, 140 MG/ML)4 QL PER 30 DAYS) AJOVY 225 MG/1.5 ML SYRINGE 3 PA, QL (1.5 3 PA, (2 ML PER 30 DAYS) EMGALITY 120 MG/ML SYRINGE 3 PA, QL (2 ML PER 30 DAYS) EMGALITY SYRINGE (100 MG/ML SYR(1 OF 3), 300 MG (100 MG X3SYR))3 PA, QL (3 SYRINGES PER 30 DAYS) ERGOMAR 2 MG TABLET SL 4 QL (22 TABS PER 30 DAYS) ergotamine tartrate/caffeine 1 mg-100mg tablet 2 naratriptan hcl (1 mg tablet, 2.5 mg tablet) 2 QL (12 TABS PER 30 DAYS) rizatriptan benzoate (5 mg tab rapdis, 5 mg tablet, 10 mg tab rapdis, 10 mg tablet)2 QL (12 TABS PER 30 DAYS) sumatriptan (5 mg spray, 20 mg spray) 2 QL (12 EACH PER 30 DAYS) sumatriptan succinate (25 mg tablet, 50 mg tablet, 100 mg tablet)2 QL (12 TABS PER 30 DAYS) sumatriptan succinate 4 mg/0.5ml QL (5 ML PER 30 DAYS) ANTIMYCOBACTERIALS cycloserine 250 mg capsule 5 PA, NM dapsone (25 mg tablet, 100 mg tablet) 2 ethambutol hcl (100 mg tablet, 400 mg tablet) 2 isoniazid (100 mg tablet, 300 mg tablet) 1 isoniazid 50 mg/5 ml solution 2 PASER GRANULES 4 GM PACKET 3 PRIFTIN 150 MG TABLET 4 pyrazinamide 500 mg tablet 2 rifabutin 150 mg capsule 2 rifampin (150 mg capsule, 300 mg capsule) 2 rifampin 600 mg vial 2 PA You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 28DRUG NAME DRUG TIERREQUIREMENTS/LIMITS SIRTURO 100 MG TABLET 5 PA, NM TRECATOR 250 MG TABLET 3 ANTINAUSEA AGENTS aprepitant (40 mg capsule, 80 mg capsule, 125mg-80mg cap ds pk, 125 mg capsule)2 PA - Part B vs D Determination COMPRO 25 MG SUPPOSITORY 2 dronabinol (2.5 mg capsule, 5 mg capsule) 2 PA - Part B vs D Determination, QL (6 CAPS PER 1 DAY) dronabinol 10 mg capsule 2 PA - Part B vs D Determination, QL (4 CAPS PER 1 DAY) EMEND 125 MG POWDER PACKET 4 PA - Part B vs D Determination granisetron hcl 1 mg tablet 2 PA - Part B vs D Determination meclizine hcl 25 mg tablet 1 ondansetron (4 mg tab rapdis, 8 mg tab rapdis) 2 PA - Part B vs D Determination ondansetron hcl (4 mg tablet, 4 mg/5 ml solution, 8 mg tablet, 24 mg tablet)2 PA - Part B vs D Determination PHENADOZ (12.5 MG, 25 MG) 2 prochlorperazine 25 mg supp.rect 2 prochlorperazine maleate (5 mg tablet, 10 mg tablet)2 promethazine hcl supp.rect, 25 mg supp.rect, 50 mg supp.rect)2 promethazine hcl (12.5 mg tablet, 25 mg tablet, 50 mg tablet)1 PROMETHEGAN (12.5 MG SUPPOS, 25 MG SUPPOSITORY, 50 MG SUPPOSITORY)2 scopolamine 1 mg/3 day patch td 3 2 trimethobenzamide hcl 300 mg capsule 2 PA - Part B vs D Determination ANTIPARASITE AGENTS albendazole 200 mg tablet 5 NM ALINIA 100 MG/5 ML SUSPENSION 4 ALINIA 500 MG 5 NM atovaquone 750 mg/5ml oral susp 5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 mg tablet, 500 mg tablet)2 COARTEM TABLETS 3 DARAPRIM 25 MG TABLET 3 hydroxychloroquine sulfate 200 mg tablet 2 ivermectin 3 mg tablet 2 mefloquine hcl 250 mg tablet 2 NEBUPENT 300 MG INHAL POWDER 3 PA - Part B vs D Determination paromomycin sulfate 250 mg capsule 2 PENTAM 300 VIAL 4 pentamidine isethionate 300 mg vial 2 praziquantel 600 mg tablet 2 primaquine phosphate 26.3 mg tablet 3 quinine sulfate 324 mg capsule 2 PA ANTIPARKINSONIAN AGENTS amantadine hcl (100 mg tablet, 100 mg capsule) 2 amantadine hcl 50 mg/5 ml solution 1 APOKYN 30 MG/3 ML CARTRIDGE 5 PA, LA, NM benztropine mesylate (0.5 mg tablet, 1 mg tablet, 2 mg tablet)2 bromocriptine mesylate (2.5 mg tablet, 5 mg capsule)2 cabergoline 0.5 mg tablet 2 carbidopa 25 mg tablet 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 INHALATION CAP 5 PA, NM NEUPRO (1 MG/24 HR PATCH, 2 MG/24 HR PATCH, 3 MG/24 HR PATCH, 4 MG/24 HR PATCH, 6 MG/24 HR PATCH, 8 MG/24 HR PATCH)4 PA pramipexole di-hcl (0.125 mg tablet, 0.25 mg tablet, 0.5 mg tablet, 0.75 mg tablet, 1 mg tablet, 1.5 mg tablet)1 pramipexole di-hcl (0.375 mg tab er 24h, 0.75 mg tab er 24h, 1.5 mg tab er 24h, 2.25 mg tab er 24h, 3 mg tab er 24h, 3.75 mg tab er 24h, 4.5 mg tab er 24h)2 rasagiline mesylate (0.5 mg tablet, 1 mg tablet) 2 ropinirole hcl (0.25 mg tablet, 0.5 mg tablet, 1 mg tablet, 2 mg tablet, 2 mg tab er 24h, 3 mg tablet, 4 mg tablet, 4 mg tab er 24h, 5 mg tablet, 6 mg tab er 24h, 8 mg tab er 24h, 12 mg tab er 24h)2 RYTARY (ER 23.75 MG-95 MG CAP, ER 36.25 MG-145 CAP, ER 48.75 MG-195 MG CAP, ER 61.25 MG-245 MG CAP)3 ST selegiline hcl (5 mg capsule, 5 mg tablet) 2 trihexyphenidyl hcl (2 mg/5 ml elixir, 2 mg tablet, 5 mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January NAME DRUG TIERREQUIREMENTS/LIMITS ANTIPSYCHOTIC AGENTS ABILIFY MAINTENA (ER 300 MG VL, ER 300 MG SYR, ER 400 MG SYR, ER 400 MG VL)5 PA - FOR NEW STARTS ONLY, NM ABILIFY MYCITE (2 MG KIT, 5 MG KIT, 10 MG KIT, 15 MG KIT, 20 MG KIT, 30 MG KIT)5 PA - FOR NEW STARTS ONLY, NM aripiprazole (1 mg/ml solution, 2 mg tablet, 5 mg tablet, 10 mg tablet, 15 mg tablet, 20 mg tablet, 30 mg tablet)2 aripiprazole (10 mg tab rapdis, 15 mg tab rapdis) 2 PA - FOR NEW STARTS ONLY ARISTADA (ER 441 MG/1.6 ML SYRN, ER 882 ONLY, NM ARISTADA ER 1064 MG/3.9 ML SYR 4 PA - FOR NEW STARTS ONLY ARISTADA INITIO ER 675 MG/2.4 5 PA - FOR NEW STARTS ONLY, NM chlorpromazine hcl (10 mg tablet, 25 mg tablet, 50 mg tablet, 100 mg tablet, 200 mg tablet)2 clozapine (12.5 mg tab rapdis, 25 mg tab rapdis, 100 mg tab rapdis, 150 mg tab rapdis, 200 mg tab rapdis)2 PA - FOR NEW STARTS ONLY clozapine (25 mg tablet, 50 mg tablet, 100 mg tablet, 200 mg tablet)2 FANAPT (1 MG TABLET, 2 MG TABLET, 4 MG TABLET, TITRATION PACK)4 PA - FOR NEW STARTS ONLY FANAPT (6 MG TABLET, 8 MG TABLET, 10 MG TABLET, 12 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM fluphenazine decanoate 25 mg/ml vial 2 fluphenazine hcl (1 mg tablet, 2.5 mg tablet, 2.5 mg/ml vial, 2.5 mg/5ml elixir, 5 mg tablet, 5 mg/ml oral conc, 10 mg tablet)2 GEODON 20 MG/ML VIAL 4 haloperidol (0.5 mg tablet, 1 mg tablet, 2 mg tablet, 5 mg tablet, 10 mg tablet, 20 mg tablet)2 haloperidol decanoate (50 mg/ml ampul, 5 mg/ml syringe)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January DRUG TIERREQUIREMENTS/LIMITS INVEGA SYRG, 234 MG/1.5 PA NEW STARTS ONLY, NM INVEGA SUSTENNA 39 MG/0.25 ML 4 PA - FOR NEW STARTS ONLY INVEGA TRINZA (273 MG/0.875 ML, 410 MG/1.315 ML, 546 MG/1.75 ML, 819 MG/2.625 ML)5 PA - FOR NEW STARTS ONLY, NM LATUDA (20 MG TABLET, 40 MG TABLET, 60 MG TABLET, 80 MG TABLET, 120 MG TABLET)5 PA - FOR NEW STARTS ONLY, QL (1 TAB PER 1 DAY), NM loxapine succinate (5 mg capsule, 10 mg capsule, 25 mg capsule, 50 mg capsule)2 molindone hcl (5 mg tablet, 10 mg tablet, 25 mg tablet)2 NUPLAZID (10 MG TABLET, 34 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM olanzapine (2.5 mg tablet, 5 mg tablet, 7.5 mg tablet, 10 mg vial, 10 mg tablet, 15 mg tablet, 20 mg tablet)2 olanzapine (5 mg tab rapdis, 10 mg tab rapdis, 15 mg tab rapdis, 20 mg tab rapdis)2 PA - FOR NEW STARTS ONLY paliperidone (1.5 mg tab er 24, 3 mg tab er 24, 6 mg tab er 24, 9 mg tab er 24)2 PA - FOR NEW STARTS ONLY perphenazine (2 mg tablet, 4 mg tablet, 8 mg tablet, 16 mg tablet)2 PERSERIS (ER 90 MG SYRINGE KIT, ER 120 MG SYRINGE KIT)5 PA - FOR NEW STARTS ONLY, NM pimozide (1 mg tablet, 2 mg tablet) 2 quetiapine fumarate (25 mg tablet, 50 mg tablet, 50 mg tab er 24h, 100 mg tablet, 150 mg tab er 24h, 200 mg tab er 24h, 200 mg tablet, 300 mg tablet, 300 mg tab er 24h, 400 mg tab er 24h, 400 mg tablet)2 REXULTI (0.25 MG TABLET, 0.5 MG TABLET, 1 MG TABLET, 2 MG TABLET, 3 MG TABLET, 4 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM RISPERDAL CONSTA (12.5 MG SYR, 25 MG SYR, 50 MG SYR)5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 33DRUG NAME DRUG TIERREQUIREMENTS/LIMITS risperidone (0.25 mg tab rapdis, 0.5 mg tab rapdis, 1 mg tab rapdis, 2 mg tab rapdis, 3 mg tab rapdis, 4 mg tab rapdis)2 PA - FOR NEW STARTS ONLY risperidone (0.25 mg tablet, 0.5 mg tablet, 1 mg tablet, 1 mg/ml solution, 2 mg tablet, 3 mg tablet, 4 mg tablet)2 SAPHRIS (10 MG TAB SL BLK CHERY, 10 MG TAB SUBLINGUAL)5 PA - FOR NEW STARTS ONLY, NM SAPHRIS (2.5 MG TAB SUBLINGUAL, 5 MG TABLET SUBLINGUAL, 5 MG TAB SUBLINGUAL, 5 MG TAB SL BLK CHERRY)4 PA - FOR NEW STARTS ONLY thioridazine hcl (10 mg tablet, 25 mg tablet, 50 mg tablet, 100 mg tablet)2 thiothixene (1 mg capsule, 2 mg capsule, 5 mg capsule, 10 mg capsule)2 trifluoperazine hcl (1 mg tablet, 2 mg tablet, 5 mg tablet, 10 mg tablet)2 VERSACLOZ 50 MG/ML SUSPENSION 5 PA - FOR NEW STARTS ONLY, NM VRAYLAR (1.5 MG CAPSULE, 3 MG CAPSULE, 4.5 MG CAPSULE, 6 MG CAPSULE)5 PA - FOR NEW STARTS ONLY, NM VRAYLAR 1.5 MG-3 MG PACK 4 PA - FOR NEW STARTS ONLY ziprasidone hcl (20 mg capsule, 40 mg capsule, 60 mg capsule, 80 mg capsule)2 ZYPREXA RELPREVV (210 MG VIAL, 210 MG VL KIT)4 PA - FOR NEW STARTS ONLY ZYPREXA RELPREVV (300 MG VL KIT, 300 MG VIAL, 405 MG VL KIT, 405 MG VIAL)5 PA - FOR NEW STARTS ONLY, NM ANTIVIRALS (SYSTEMIC) ANTIRETROVIRALS abacavir MG/ML SOLUTION, 250 MG CAPSULE)5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 34DRUG NAME DRUG TIERREQUIREMENTS/LIMITS atazanavir sulfate (150 mg capsule, 300 mg capsule)5 NM atazanavir sulfate 200 mg capsule 2 ATRIPLA BIKTARVY 50-200-25 MG NM COMPLERA TABLET (200 MG CAPSULE, DELSTRIGO 100-300-300 5 NM DESCOVY 200-25 MG TABLET 5 NM didanosine (125 mg capsule dr, 200 mg capsule dr, 250 mg capsule dr, 400 mg capsule dr)2 DOVATO 50-300 MG TABLET 5 NM EDURANT 25 MG TABLET 5 NM efavirenz (50 mg capsule, 200 mg capsule) 2 efavirenz 600 mg tablet 5 NM EMTRIVA (10 MG/ML MG TABLET 5 NM fosamprenavir calcium 700 mg tablet 5 NM FUZEON (90 VIAL, CONVENIENCE KIT)5 NM GENVOYA TABLET INTELENCE (100 MG TABLET, MG TABLET)5 NM INTELENCE 25 MG TABLET 4 INVIRASE 500 MG TABLET 5 NM ISENTRESS (100 MG POWDER PACKET, 100 MG TABLET CHEW, 400 MG TABLET)5 NM ISENTRESS 25 MG TABLET CHEW 3 ISENTRESS HD 600 MG TABLET 5 NM JULUCA 50-25 MG TABLET 5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 DRUG TIERREQUIREMENTS/LIMITS KALETRA 100-25 TABLET MG TABLET 5 NM lamivudine (10 mg/ml solution, 100 mg tablet, 150 mg tablet, 300 mg tablet)2 lamivudine/zidovudine 150-300mg tablet 2 LEXIVA 50 solution 2 nevirapine (50 mg/5 ml oral susp, 100 mg tab er 24h, 200 mg tablet, 400 mg tab er 24h)2 NORVIR (80 MG/ML SOLUTION, 100 MG SOFTGEL CAP, 100 MG POWDER PACKET)4 ODEFSEY TABLET 5 NM PIFELTRO 100 MG TABLET 800 MG-150 MG TABLET 5 NM PREZISTA (100 MG/ML SUSPENSION, 150 MG TABLET, 600 MG TABLET, 800 MG TABLET)5 NM PREZISTA 75 MG TABLET 4 RESCRIPTOR (100 MG TABLET, 200 MG TABLET)4 REYATAZ 50 MG POWDER PACKET 5 NM ritonavir 100 mg tablet 2 SELZENTRY (20 MG/ML ORAL SOLN, 25 MG TABLET)4 SELZENTRY (75 MG TABLET, 150 MG TABLET, 300 MG TABLET)5 NM stavudine (15 mg capsule, 20 mg capsule, 30 mg capsule, 40 mg capsule)2 STRIBILD TABLET 5 NM SYMFI 600-300-300 MG tenofovir disoproxil fumarate 300 mg tablet 2 TIVICAY (25 MG TABLET, 50 MG TABLET) 5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 36DRUG NAME DRUG TIERREQUIREMENTS/LIMITS TIVICAY 10 MG TABLET 4 TRIUMEQ 600-50-300 MG TABLET 5 NM TRUVADA (100 MG-150 MG TABLET, 133 MG-200 MG TABLET, MG-250 MG TABLET, 200 MG-300 MG TABLET)5 NM VEMLIDY 25 MG TABLET 5 (2 GM SOLN, 4 GM SOLN) 4 VIDEX EC 125 MG CAPSULE 4 VIRACEPT (250 MG TABLET, 625 MG TABLET)5 NM VIREAD (150 MG TABLET, 200 MG TABLET, 250 MG TABLET, POWDER)5 NM zidovudine (10 mg/ml syrup, 100 mg capsule, ANTIVIRALS, MISCELLANEOUS oseltamivir phosphate (6 mg/ml susp recon, 30 mg capsule, 45 mg capsule, 75 mg capsule)2 PREVYMIS (240 MG TABLET, 480 MG TABLET)5 NM RELENZA 5 MG DISKHALER tablet 2 HCV ANTIVIRALS TABLET, 60 MG 90mg-400mg tablet 5 NM sofosbuvir/velpatasvir 400-100 mg tablet 5 PA, NM TECHNIVIE DOSE PA, NM VIEKIRA PAK 5 VOSEVI 400-100-100 MG TABLET 5 PA, NM INTERFERONS INTRON A (10 MILLION UNITS VIL, 18 MILLION UNITS VIL, 18 MILLION UNIT/3 ML, 25 MILLION UNIT/2.5ML, 50 MILLION UNITS VIL)5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 37DRUG NAME DRUG TIERREQUIREMENTS/LIMITS PEGASYS (180 ML PA, NUCLEOSIDES AND NUCLEOTIDES acyclovir mg tablet, 800 mg tablet)1 acyclovir 200 mg/5ml oral susp 2 acyclovir sodium (50 mg/ml vial, 500 mg vial, 1000 mg vial)2 PA - Part B vs D Determination adefovir dipivoxil 10 mg tablet 5 NM BARACLUDE 0.05 MG/ML SOLUTION 4 entecavir (0.5 mg tablet, 1 mg tablet) 2 famciclovir (125 mg tablet, 250 mg tablet, 500 mg tablet)2 REBETOL 40 MG/ML SOLUTION 4 RIBASPHERE (200 (200 capsule, 200 mg tablet) 2 ribavirin 6 g vial-neb 5 PA, NM valacyclovir hcl (500 mg tablet, tablet) EXPANDERS ANTICOAGULANTS ELIQUIS (2.5 MG TABLET, 5 MG STARTER PACK, 5 MG TABLET)3 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January MG TABLET, 2 MG TABLET, 2.5 MG TABLET, 3 MG TABLET, 4 MG TABLET, 5 MG TABLET, 6 MG TABLET, 7.5 MG TABLET, 10 MG TABLET)1 PRADAXA (75 MG CAPSULE, 110 MG CAPSULE, 150 MG CAPSULE)4 PA warfarin sodium (1 mg tablet, 2 mg tablet, 2.5 mg tablet, 3 mg tablet, 4 mg tablet, 5 mg tablet, 6 mg tablet, 7.5 mg tablet, 10 mg tablet)1 XARELTO (2.5 MG TABLET, 10 MG TABLET, 15 MG TABLET, 20 MG TABLET, STARTER PACK)3 BLOOD FORMATION MODIFIERS ARANESP (10 MCG/0.4 ML SYRINGE, MCG/0.3 ML SYRINGE, 150 MCG/0.75 ML 200 MCG/ML VIAL, 200 MCG/0.4 ML SYRINGE, 300 MCG/ML VIAL, SYRINGE)5 PA, NM, BvsD BERINERT (500 UNIT KIT, 500 UNIT VIAL) 5 PA, LA, NM CINRYZE 500 UNIT VIAL 5 PA, LA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, SAFE 480 ML MCG/1.6 VIAL)5 NM HAEGARDA UNIT UNIT LEUKINE 250 MCG VIAL 5 SYR)5 PROCRIT (2,000 NM, BvsD PROMACTA (12.5 MG SUSPEN PACKET, 12.5 MG TABLET, 25 MG TABLET, 50 MG TABLET, 75 MG TABLET)5 PA, LA, NM RETACRIT (2,000 UNIT/ML VIAL, 3,000 UNIT/ML 5 VIAL AGENTS, MISCELLANEOUS anagrelide hcl (0.5 mg capsule, 1 mg capsule) 2 tranexamic acid 650 mg tablet 2 QL (30 TABS PER 30 DAYS) PLATELET-AGGREGATION INHIBITORS aspirin/dipyridamole 25mg-200mg cpmp 12hr 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 40DRUG NAME DRUG TIERREQUIREMENTS/LIMITS BRILINTA (60 MG TABLET, 90 MG TABLET)3 cilostazol (50 mg tablet, 100 mg tablet) 2 clopidogrel bisulfate 75 mg tablet 1 dipyridamole (25 mg tablet, 50 mg tablet, 75 mg tablet)2 pentoxifylline 400 mg tablet er 2 prasugrel hcl (5 mg tablet, 10 mg tablet) 2 ZONTIVITY 2.08 MG TABLET 3 PA CALORIC AGENTS AMINOSYN 8.5%-ELECTROLYTES SOL 3 PA - Part B vs D Determination AMINOSYN II (7% IV SOLUTION, 8.5% IV SOLUTION, 10% IV SOLUTION, 15% IV SOLUTION)3 PA - Part B vs D Determination AMINOSYN II 8.5%-ELECTROLYTES 3 PA - Part B vs D Determination AMINOSYN M 3.5% IV SOLUTION 3 PA - Part B vs D Determination AMINOSYN-HBC 7% IV SOLUTION 3 PA - Part B vs D Determination AMINOSYN-PF (7% IV SOLUTION, 10% IV SOLUTION)3 PA - Part B vs D Determination dextrose 10 % in water (10 % in 10 % dehp fr bg, 10 % in 10 % iv soln)2 dextrose 5 % in water (5 % in pggybk prt, 5 % in pgy vl prt, 5 % in 5 % iv soln, 5 % in 5 % vial)2 INTRALIPID (20% IV EMUL, 30% IV EMUL)3 PA - Part B vs D Determination CARDIOVASCULAR AGENTS ALPHA-ADRENERGIC AGENTS clonidine 0.2 mg tablet, 0.3 mg tablet)1 doxazosin mesylate (1 mg tablet, 2 mg tablet, 4 mg tablet, 8 mg tablet)2 guanfacine hcl (1 mg tablet, 2 mg tablet) 1 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 41DRUG NAME DRUG TIERREQUIREMENTS/LIMITS methyldopa (250 mg tablet, 500 mg tablet) 2 midodrine hcl (2.5 mg tablet, 5 mg tablet, 10 mg tablet)2 NORTHERA (100 MG CAPSULE, 200 MG CAPSULE)5 PA, QL (90 CAPS PER 30 DAYS), NM NORTHERA 300 MG CAPSULE 5 PA, QL (180 CAPS PER 30 DAYS), NM phenoxybenzamine hcl 10 mg capsule 5 PA, NM prazosin hcl (1 mg capsule, 2 mg capsule, 5 mg capsule)2 ANGIOTENSIN II RECEPTOR ANTAGONISTS ENTRESTO (24 MG-26 MG TABLET, 49 MG-51 MG TABLET, 97 MG-103 MG TABLET)3 irbesartan (75 mg tablet, 150 mg tablet)1 losartan olmesartan medoxomil/hydrochlorothiazide (olmesartan/hydrochlorothiazide 25mg tablet)2 telmisartan mg tablet, 40 mg tablet, 80 mg tablet)2 valsartan (40 mg tablet, 80 mg tablet, 160 mg tablet, 320 mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 (5 mg tablet, 10 mg tablet, 20 mg tablet, 40 mg tablet)1 mg-25mg tablet)2 captopril (12.5 mg tablet, 25 mg tablet, 50 mg tablet, 100 mg tablet)2 captopril/hydrochlorothiazide (captopril/hydrochlorothiazide 25 mg-25mg tablet)2 enalapril maleate (2.5 mg tablet, 5 mg tablet, mg tablet, 20 mg tablet)2 (2.5 mg tablet, 5 mg tablet, 10 mg tablet, 20 mg tablet, 30 mg tablet, 40 mg tablet)1 lisinopril/hydrochlorothiazide (lisinopril/hydrochlorothiazide moexipril hcl (7.5 mg tablet, 15 mg tablet) 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 43DRUG NAME DRUG TIERREQUIREMENTS/LIMITS perindopril erbumine (2 mg tablet, 4 mg tablet, 8 mg tablet)2 quinapril hcl (5 mg tablet, 10 mg tablet, 20 mg tablet, 40 mg tablet)1 quinapril hcl/hydrochlorothiazide tablet)2 ramipril (1.25 mg capsule, 2.5 mg capsule, 5 mg capsule, 10 mg capsule)1 trandolapril (1 mg tablet, 2 mg tablet, 4 mg tablet)1 ANTIARRHYTHMIC AGENTS amiodarone hcl (100 mg tablet, 200 mg tablet, 400 mg tablet)2 disopyramide phosphate (100 mg capsule, 150 mg capsule)2 dofetilide mcg capsule, 250 mcg capsule, 500 mcg capsule)2 flecainide acetate (50 mg tablet, 100 mg tablet, 150 mg tablet)2 mexiletine hcl (150 mg capsule, 200 mg capsule, 250 mg capsule)2 MULTAQ 400 MG TABLET 4 PA NORPACE CR (CR 100 MG CAPSULE, CR 150 MG CAPSULE)4 PACERONE (100 MG TABLET, 200 MG TABLET, 400 MG TABLET)2 propafenone hcl (150 mg tablet, 225 mg tablet, 300 mg tablet)2 quinidine gluconate 324 mg tablet er 2 quinidine sulfate (200 mg tablet, 300 mg tablet) 2 BETA-ADRENERGIC BLOCKING AGENTS atenolol (25 mg tablet, 50 mg tablet, 100 mg tablet)1 atenolol/chlorthalidone (atenolol/chlorthalidone 50 mg-25mg tablet, atenolol/chlorthalidone 100mg-25mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 44DRUG NAME DRUG TIERREQUIREMENTS/LIMITS bisoprolol fumarate (5 mg tablet, (3.125 mg tablet, 6.25 mg tablet, 12.5 mg tablet, 25 mg tablet)1 labetalol hcl (100 mg tablet, 200 mg tablet, 300 mg tablet)2 metoprolol succinate (25 mg tab er 24h, 50 mg tab er 24h, 100 mg tab er 24h, 200 mg tab er 24h)2 metoprolol tartrate (25 mg tablet, 50 mg tablet, mg tablet, 80 mg tablet)2 propranolol hcl (10 mg tablet, 20 mg tablet, 20 mg/5 ml solution, 40mg/5ml solution, 40 mg tablet, 60 mg tablet, 60 mg cap sa 24h, 80 mg cap sa 24h, 80 mg tablet, 120 mg cap sa 24h, 160 mg cap sa 24h)2 propranolol/hydrochlorothiazid 80 tablet)2 sotalol hcl (80 mg tablet, 120 mg tablet, 160 mg tablet, 240 mg tablet)2 CALCIUM-CHANNEL BLOCKING AGENTS CARTIA XT (120 MG CAPSULE, 180 MG CAPSULE, 240 MG CAPSULE, 300 MG CAPSULE)2 DILT-CD (120 MG CAPSULE, 180 MG CAPSULE, 240 MG CAPSULE)2 DILT-XR (120 MG CAPSULE, 180 MG CAPSULE, 240 MG CAPSULE)2 diltiazem 24hr er 360 mg cap (generic for cardizem cd)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 45DRUG NAME DRUG TIERREQUIREMENTS/LIMITS diltiazem hcl (30 mg tablet, 60 mg tablet, 90 mg tablet, 120 mg cap sa 24h, 120 mg cap er 24h, 120 mg cap er deg, 120 mg tablet, 180 mg cap sa 24h, 180 mg cap er 24h, 180 mg cap er deg, 240 mg cap er deg, 240 mg cap er 24h, 240 mg cap sa 24h, 300 mg cap er 24h, 300 mg cap sa 24h, 360 mg cap sa 24h, 420 mg cap sa 24h)2 MATZIM LA (180 MG TABLET, 240 MG TABLET, 300 MG TABLET, 420 MG TABLET)2 MATZIM LA 360 MG TABLET (GENERIC FOR CARDIZEM LA)2 TAZTIA XT (120 MG CAPSULE, 180 MG CAPSULE, 240 MG CAPSULE, 300 MG CAPSULE, 360 MG CAPSULE)2 verapamil hcl (120 mg cap24h pel, 120 mg tablet er, 180 mg tablet er, 180 mg cap24h pel, 240 mg cap24h pel, 240 mg tablet er, 360 mg cap24h pel)2 verapamil hcl (40 mg tablet, 80 mg tablet, 120 mg tablet)1 CARDIOVASCULAR AGENTS, MISCELLANEOUS CORLANOR (5 MG/5 ML ORAL SOLN, 5 MG TABLET, 7.5 MG TABLET)4 PA DEMSER 250 MG CAPSULE 5 PA, NM DIGITEK 125 MCG TABLET 2 QL (30 TABS PER 30 DAYS) DIGITEK 250 MCG TABLET 2 PA DIGOX 125 MCG TABLET 2 QL (30 TABS PER 30 DAYS) DIGOX 250 MCG TABLET 2 PA digoxin 125 mcg tablet 2 QL (30 TABS PER 30 DAYS) digoxin 250 mcg tablet 2 PA digoxin 50 (18 ML PER 30 DAYS), NM hydralazine hcl (10 mg tablet, 25 mg tablet, 50 mg tablet, 100 mg tablet)2 icatibant acetate 30 mg/3 ml syringe 5 PA, QL (18 ML PER 30 DAYS), NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 46DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ranolazine (500 mg tab er 12h, 1000 mg tab er 12h)2 PA VYNDAMAX 61 MG CAPSULE 5 PA, NM VYNDAQEL 20 MG CAPSULE 5 PA, NM DIHYDROPYRIDINES AFEDITAB CR (CR 30 MG TABLET, CR 60 MG TABLET)2 amlodipine besylate (2.5 mg tablet, 5 besylate/benazepril capsule, 5 10mg-160mg tablet)2 nifedipine (30 mg tablet er, 30 mg tab er 24, 60 mg tablet er, 60 mg tab er 24, 90 mg tab er 24, 90 mg tablet er)2 nimodipine 30 mg capsule 2 DIURETICS amiloride hcl 5 mg tablet 2 amiloride/hydrochlorothiazide 5 mg-50 mg tablet 2 bumetanide (0.5 mg tablet, 1 mg tablet, 2 mg tablet)2 chlorothiazide (250 mg tablet, 500 mg tablet) 2 chlorthalidone (25 mg tablet, 50 mg tablet) 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 NAME DRUG TIERREQUIREMENTS/LIMITS DIURIL 250 MG/5 ML ORAL SUSP 4 furosemide (10 mg/ml solution, 20 mg tablet, 40mg/5ml solution, 40 mg tablet, 80 mg tablet)1 furosemide (10 mg/ml vial, 10 mg/ml syringe) 2 hydrochlorothiazide (12.5 mg capsule, 12.5 mg tablet, 25 mg tablet, 50 mg tablet)1 indapamide (1.25 mg tablet, 2.5 mg tablet) 2 metolazone (2.5 mg tablet, 5 mg tablet, 10 mg tablet)2 spironolact/hydrochlorothiazid 25 mg-25mg tablet 2 spironolactone (25 mg tablet, 50 mg tablet, 100 mg tablet)1 torsemide (5 mg tablet, 10 mg tablet, 20 mg tablet, 100 mg tablet)2 triamterene/hydrochlorothiazide (triamterene/hydrochlorothiazid 37.5-25 tablet)1 DYSLIPIDEMICS atorvastatin calcium (10 mg tablet, 20 mg tablet, 40 mg tablet, 80 mg tablet)1 cholestyramine (with sugar) (sugar) 4 g powd pack, sugar) 4 g powder)2 cholestyramine/aspartame (cholestyramine/aspartame pack, cholestyramine/aspartame colestipol hcl 1 g tablet 2 ezetimibe 10 mg tablet 2 fenofibrate (54 mg tablet, 160 mg tablet) 2 fenofibrate nanocrystallized (48 mg tablet, 145mg tablet, 160 mg tablet)2 fenofibrate,micronized (43 mg capsule, 67 mg capsule, 130 mg capsule, 134 mg capsule, 200 mg capsule)2 gemfibrozil 600 mg tablet 1 JUXTAPID (5 MG CAPSULE, 10 MG CAPSULE, 20 MG CAPSULE, 30 MG CAPSULE, 40 MG CAPSULE, 60 MG CAPSULE)5 PA, LA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 48DRUG NAME DRUG TIERREQUIREMENTS/LIMITS lovastatin (10 mg tablet, 20 mg tablet, 40 mg tablet)1 niacin (500 mg tab er 24h, 750 mg tab er 24h, 1000 mg tab er 24h)2 omega-3 acid ethyl esters 1 g capsule 2 pravastatin sodium (10 mg tablet, 20 mg tablet, 40 mg tablet, 80 mg tablet)1 PREVALITE (PACKET, POWDER) 2 REPATHA 4 PA, NM rosuvastatin calcium (5 mg tablet, 10 mg tablet, 20 mg tablet, 40 mg tablet)2 simvastatin (5 mg tablet, 10 mg tablet, 20 mg tablet, 40 mg tablet, 80 mg tablet)1 TRIKLO 1 GM CAPSULE 2 RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS aliskiren hemifumarate (150 mg tablet, 300 mg tablet)2 eplerenone (25 mg tablet, 50 mg tablet) 2 VASODILATORS isosorbide dinitrate (5 mg tablet, 10 mg tablet, 20 mg tablet, 30 mg tablet, 40 mg tablet er)2 isosorbide mononitrate (10 mg tablet, 20 mg tablet, 30 mg tab er 24h, 60 mg tab er 24h, 120 mg tab er 24h)2 MINITRAN (0.1 MG/HR PATCH, MG/HR PATCH, 0.4 MG/HR PATCH, 0.6 MG/HR PATCH)2 minoxidil (2.5 mg tablet, 10 tablet) 2 nitroglycerin (0.1mg/hr patch td24, 0.2mg/hr patch td24, 0.3 0.4 mg tab subl, 0.6mg/hr patch td24, 0.6 mg tab subl)2 CENTRAL NERVOUS SYSTEM AGENTS atomoxetine hcl (10 mg capsule, 18 mg capsule, 25 mg capsule, 40 mg capsule)2 QL (2 CAPS PER 1 DAY) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 49DRUG NAME DRUG TIERREQUIREMENTS/LIMITS atomoxetine hcl (60 mg capsule, 80 mg capsule, 100 mg capsule)2 QL (1 CAP PER 1 DAY) AUBAGIO (7 MG TABLET, 14 MG TABLET)5 QL (30 TABS PER 30 DAYS), NM AUSTEDO (6 MG TABLET, 9 MG TABLET, 12 MG NM PER DAYS), NM AVONEX 30 MCG VIAL KIT 5 QL (4 EACH PER 28 DAYS), NM AVONEX PEN (PEN 30 MCG/0.5 ML KIT, PEN 30 MCG/0.5 ML)5 QL (1 EACH PER 28 DAYS), NM BETASERON (0.3 MG VIAL, 0.3 MG KIT) 5 QL (14 DOSES PER 28 DAYS), NM clonidine hcl 0.1 mg tab er 12h 2 PA, QL (4 TABS PER 1 DAY) dalfampridine 10 mg tab er 12h 5 PA, QL (2 TABS PER 1 DAY), NM dexmethylphenidate hcl (2.5 mg tablet, 5 mg tablet, 10 mg tablet)2 QL (2 TABS PER 1 DAY) dexmethylphenidate hcl (25 50-50, 30 50-50, 10 dextroamphetamine sulf-saccharate/amphetamine (dextroamphetamine/amphetamine 15 mg tablet, dextroamphetamine/amphetamine 20 mg tablet, dextroamphetamine/amphetamine 30 mg tablet)2 QL (2 TABS PER 1 DAY) sulf-saccharate/amphetamine sulf-aspartate (dextroamphetamine/amphetamine 5 mg cap er 24h, dextroamphetamine/amphetamine 10 mg cap er 24h, dextroamphetamine/amphetamine 15 mg cap er 24h, dextroamphetamine/amphetamine 20 mg cap er 24h, dextroamphetamine/amphetamine 25 mg cap er 24h, dextroamphetamine/amphetamine 30 mg cap er 24h)2 QL (2 CAPS PER 1 DAY) dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate (dextroamphetamine/amphetamine 5 mg tablet, dextroamphetamine/amphetamine 7.5 mg dextroamphetamine/amphetamine 10 mg tablet, dextroamphetamine/amphetamine 12.5 mg tablet)2 QL (3 TABS PER 1 DAY) You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 50DRUG NAME DRUG TIERREQUIREMENTS/LIMITS dextroamphetamine sulfate (5 mg capsule er, 10 mg capsule er, 15 mg capsule er)2 QL (4 CAPS PER 1 DAY) dextroamphetamine sulfate (5 mg tablet, 10 mg tablet)2 QL (6 TABS PER 1 DAY) GILENYA (0.25 MG CAPSULE, 0.5 MG CAPSULE)5 QL (30 CAPS PER 30 DAYS), NM glatiramer acetate 20 mg/ml syringe 5 QL (30 DAYS), NM glatiramer acetate 40 mg/ml syringe 5 QL DAYS), NM GLATOPA 20 MG/ML SYRINGE 5 QL NM GLATOPA 40 MG/ML SYRINGE 5 QL (12 ML PER DAYS), NM guanfacine hcl (3 mg tab er 24h, 4 mg tab er 24h) 2 QL (1 TAB PER 1 DAY) guanfacine hcl 1 mg tab er 24h 2 QL (3 TABS PER 1 DAY) guanfacine hcl 2 mg tab er 24h 2 QL (2 TABS PER 1 DAY) INGREZZA (40 MG CAPSULE, 80 MG CAPSULE)5 PA, NM INGREZZA INITIATION PACK 5 PA, NM lithium carbonate (150 mg capsule, 300 mg capsule, 600 mg capsule)1 lithium carbonate (300 mg tablet, 300 mg tablet er, 450 mg tablet er)2 lithium citrate 8 meq/5 ml solution 2 MAVENCLAD (10 MG 10 TABLET PK, 10 MG 6 TABLET PK, 10 MG 4 TABLET PK, 10 MG 9 TABLET PK, 10 MG 8 TABLET PK, 10 MG 5 TABLET PK, 10 MG 7 TABLET PK)5 PA, NM MAYZENT (0.25 MG STARTER PACK, 0.25 MG TABLET)5 QL (4 TABS PER 1 DAY), NM MAYZENT 2 MG TABLET 5 QL (30 TABS PER 30 DAYS), NM methylphenidate hcl (10 50-50, 40 (1 CAP PER 1 DAY) methylphenidate hcl (5 mg tablet, 10 mg tablet er, 10 mg tablet, 20 mg tablet er, 20 mg tablet)2 QL (3 TABS PER 1 DAY) NUEDEXTA 20-10 MG CAPSULE 5 PA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, ML SYRING, PER 28 DAYS), NM PLEGRIDY PEN (125 MCG/0.5 ML PEN, PEN INJ STARTER PACK)5 QL (1 ML PER 28 DAYS), ML SYRINGE, 44 MCG/0.5 MCG/0.5 ML, 44 NM REBIF REBIDOSE TITRATION PACK 5 QL (4.2 DAYS), NM REBIF TITRATION PACK 5 QL (4.2 ML PER 28 DAYS), NM riluzole 50 mg tablet 2 SAVELLA (12.5 MG TABLET, 25 MG TABLET, 50 MG TABLET, 100 MG TABLET, TITRATION PACK)4 TECFIDERA (DR 120 MG CAPSULE, DR 240 MG CAPSULE, STARTER PACK)5 QL (60 CAPS PER 30 DAYS), NM tetrabenazine (12.5 mg tablet, 25 mg tablet) 5 PA, LA, NM VYVANSE (10 MG CAPSULE, 20 MG CAPSULE, 30 MG CAPSULE)4 QL (2 CAPS PER 1 DAY) VYVANSE (10 MG TABLET, 20 MG TABLET, 30 MG TABLET)4 QL (2 TABS PER 1 DAY) VYVANSE (40 MG CAPSULE, 50 MG CAPSULE, 60 MG CAPSULE, 70 MG CAPSULE)4 QL (1 CAP PER 1 DAY) VYVANSE (40 MG TABLET, 50 MG TABLET, 60 MG TABLET)4 QL (1 TAB PER 1 DAY) CONTRACEPTIVES AFIRMELLE-28 TABLET 2 ALTAVERA-28 TABLET 2 ALYACEN (1-35 TABLET)2 MG TAB 2 AMETHIA LO TABLET 2 APRI 28 DAY TABLET 2 ARANELLE 28 TABLET 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 DRUG TIERREQUIREMENTS/LIMITS ASHLYNA 0.15-0.03-0.01 MG TAB 2 AUBRA TABLET 2 TABLET 2 AVIANE-28 TABLET 2 AYUNA-28 TABLET 2 AZURETTE 28 DAY TABLET 2 BALZIVA 28 TABLET 2 BEKYREE 28 DAY TABLET 2 BLISOVI FE (1-20 TABLET, 1.5-30 TABLET) 2 BREVICON 28 TABLET 2 BRIELLYN TABLET 2 CAMILA 0.35 MG TABLET 2 CAMRESE 0.15-0.03-0.01 MG TAB 2 CAMRESE LO TABLET 2 CAZIANT 28 DAY TABLET 2 CHATEAL EQ-28 TABLET 2 CHATEAL-28 CYRED 28 DASETTA DAYSEE 0.15-0.03-0.01 MG TAB MG TABLET 2 DELYLA-28 TABLET 2 desog-e.estradiol/e.estradiol 21-5 (28) tablet 2 desogestrel-ethinyl estradiol 0.15-0.03 tablet 2 ELINEST-28 TABLET 2 ELLA 30 MG TABLET 3 EMOQUETTE 28 DAY TABLET 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 53DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ENPRESSE-28 TABLET 2 ENSKYCE 28 TABLET 2 ERRIN 0.35 MG TABLET 2 ESTARYLLA FEMYNOR TABLET 2 GIANVI MG-0.02 MG TABLET 2 HAILEY 21 1.5 MG-30 MCG TAB 2 HAILEY 24 FE 1 MG-20 MCG TAB 2 HEATHER 0.35 MG TABLET 2 INCASSIA 0.35 MG TABLET 2 INTROVALE 0.15-0.03 MG TABLET 2 ISIBLOOM 28 DAY TABLET 2 JASMIEL 3 MG-0.02 MG TABLET 2 JENCYCLA 0.35 MG TABLET 2 JOLESSA 0.15 MG-0.03 MG TABLET 2 JOLIVETTE TABLET 2 JULEBER 28 DAY TABLET 2 KALLIGA 28 2 KARIVA 28 TABLET 2 KELNOR 1-35 28 TABLET 2 KELNOR 1-50 TABLET 2 LARIN (1.5 MG-30 MCG TABLET, 21 1-20 TABLET)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, NAME DRUG TIERREQUIREMENTS/LIMITS LARIN FE (1-20 TABLET, 1.5-30 TABLET) 2 LARISSIA-28 TABLET 2 LEENA 28 TABLET 2 LESSINA-28 TABLET 2 TB 2 LORYNA 3 MG-0.02 MG TABLET 2 LOW-OGESTREL-28 TABLET 2 LUTERA-28 TABLET 2 LYZA 0.35 MG TABLET 2 MARLISSA-28 TABLET 2 MICROGESTIN (21 MONO-LINYAH 28 TABLET MONONESSA 28 TABLET 2 MYZILRA-28 TABLET 2 NECON 0.5-35-28 TABLET 2 NIKKI 3 MG-0.02 MG TABLET 2 NORA-BE TABLET 2 norethindrone 0.35 mg tablet)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 NORLYDA 0.35 MG TABLET 2 NORLYROC 0.35 MG TABLET 2 NORTREL (0.5-35-28 TABLET, 1-35 1-35 28 3 MG-0.03 MG OGESTREL TABLET ORSYTHIA-28 TABLET 2 PHILITH 0.4-0.035 MG TABLET 2 PIMTREA TABLET (1-35-28 TABLET, 7-7-7-28 TABLET)2 PORTIA-28 TABLET 2 PREVIFEM RECLIPSEN 28 DAY TABLET 2 SETLAKIN 0.15 MG-0.03 MG TAB 2 SHAROBEL 0.35 MG TABLET 2 SIMLIYA 28 DAY TABLET 2 SIMPESSE 0.15-0.03-0.01 MG TAB 2 SPRINTEC 28 DAY TABLET 2 SRONYX 0.10-0.02 MG TABLET 2 SYEDA 28 TABLET 2 TARINA 24 FE 1 MG-20 MCG TAB 2 TARINA FE EQ TABLET 2 TARINA FE 1-20 TABLET 2 TILIA FE 28 TABLET 2 TRI FEMYNOR 28 TABLET 2 TRI-ESTARYLLA TABLET 2 TRI-LEGEST FE-28 DAY TABLET 2 TRI-LINYAH TABLET 2 TRI-LO-ESTARYLLA TABLET 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 56DRUG NAME DRUG TIERREQUIREMENTS/LIMITS TRI-LO-MARZIA TABLET 2 TRI-LO-MILI TABLET 2 TRI-LO-SPRINTEC TABLET 2 TRI-MILI 28 TABLET 2 TRI-PREVIFEM TABLET 2 TRI-SPRINTEC TABLET 2 TRI-VYLIBRA 28 TABLET 2 TRI-VYLIBRA LO TABLET 2 TRIVORA-28 TABLET 2 TULANA 0.35 MG TABLET 2 VELIVET 28 DAY TABLET 2 VIENVA-28 TABLET 2 VIORELE 28 DAY TABLET 2 VYFEMLA 28 TABLET 2 VYLIBRA 28 TABLET 2 WERA 0.5/0.035 MG 28 TABLET 2 XULANE PATCH 2 ZARAH 2 ZENCHENT 0.4 MG-35 2 ZOVIA 1-35E TABLET 2 ZUMANDIMINE 3 MG-0.03 MG TAB 2 DENTAL AND ORAL AGENTS cevimeline hcl 30 mg capsule 2 chlorhexidine gluconate 0.12 % mouthwash 1 fluoride (sodium) ((sodium) 1.1 % cream (g), (sodium) 1.1 % gel (gram))1 PAROEX 0.12% ORAL RINSE 1 PERIOGARD 0.12% ORAL RINSE 1 pilocarpine hcl (5 mg tablet, 7.5 mg tablet) 2 triamcinolone acetonide 0.1 % paste (g) 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 NAME DRUG TIERREQUIREMENTS/LIMITS DERMATOLOGICAL AGENTS DERMATOLOGICAL AGENTS, OTHER acitretin (10 mg capsule, 17.5 mg capsule, 25 mg capsule)2 ammonium lactate (12 % lotion, 12 % cream (g))2 AMNESTEEM (10 MG CAPSULE, 20 MG CAPSULE, 40 MG CAPSULE)2 azelaic acid 15 % gel (gram) 2 calcipotriene (0.005 % oint. (g), 0.005 % calcitriol 3 mcg/g oint. (g) 2 CLARAVIS (10 MG CAPSULE, 20 MG CAPSULE, 30 MG CAPSULE, 40 MG CAPSULE)2 CONDYLOX 0.5% GEL 4 COSENTYX 150 COSENTYX SYRINGE 5 PA, PA, NM FINACEA 15% FOAM 4 fluorouracil (2 % solution, 5 % cream (g), 5 % solution)2 fluorouracil 0.5 % cream (g) 5 NM imiquimod 5 % cream pack 2 methoxsalen 10 mg cap lq rap 5 PA - FOR NEW STARTS ONLY, NM MYORISAN (10 MG CAPSULE, 20 MG CAPSULE, 30 MG CAPSULE, 40 MG CAPSULE)2 PANRETIN 0.1% GEL 5 NM PICATO (0.015% GEL, 0.05% GEL) 5 NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 58DRUG NAME DRUG TIERREQUIREMENTS/LIMITS podofilox 0.5 % solution 2 GEL PA, NM VALCHLOR 0.016% GEL 5 PA - FOR NEW STARTS ONLY, QL (120 GM PER 30 DAYS), NM VEREGEN 15% OINTMENT 4 ZENATANE (10 MG CAPSULE, 20 MG CAPSULE, 30 MG CAPSULE, 40 MG CAPSULE)2 DERMATOLOGICAL ANTI-INFLAMMATORY AGENTS alclometasone dipropionate cream (g))2 betamethasone dipropionate (0.05 % oint. (g), 0.05 % lotion, 0.05 % cream (g), 0.05 % gel (gram))2 betamethasone dipropionate/propylene glycol (betamethasone/propylene 0.05 % oint. (g), betamethasone/propylene 0.05 % lotion)2 betamethasone valerate (0.1 % cream (g), 0.1 % lotion, 0.1 % oint. (g))2 clobetasol propionate (0.05 % gel (gram), 0.05 % solution, 0.05 % oint. (g), 0.05 % cream (g))2 clobetasol propionate/emoll 0.05 % cream (g) 2 CORDRAN (4 MCG/SQ CM TAPE LARGE, 4 MCG/SQ CM TAPE SMALL)5 NM desonide (0.05 % lotion, 0.05 % oint. (g), 0.05 % cream (g))2 desoximetasone (0.05 % cream (g), 0.05 % gel (gram), 0.05 % oint. (g), 0.25 % oint. (g), 0.25 % cream (g))2 EUCRISA 2% OINTMENT 4 PA, QL (60 GM PER 30 DAYS) fluocinolone acetonide (0.01 % oil, 0.01 % cream (g), 0.025 % oint. (g), 0.025 % cream (g))2 fluocinolone/shower cap 0.01 % oil 2 fluocinonide (0.05 % oint. (g), 0.05 % cream (g), 0.05 % gel (gram), 0.05 % solution)2 fluocinonide/emollient base 0.05 % cream (g) 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 DRUG TIERREQUIREMENTS/LIMITS fluticasone % % cream (g))2 hydrocortisone (2.5 % crm/pe app, 2.5 % cream (g), 2.5 % lotion)2 hydrocortisone 2.5 % oint. (g) 1 hydrocortisone valerate cream (g), 0.2 % oint. (g))2 mometasone furoate (0.1 % oint. (g), 0.1 % cream (g), 0.1 % solution)2 pimecrolimus 1 % cream (g) 2 PROCTO-MED PROCTOSOL-HC 2.5% 2 tacrolimus (0.03 oint. (g), 0.1 % oint. (g)) 2 triamcinolone acetonide (0.025 % oint. (g), 0.025 % cream (g), 0.025 % lotion, 0.1 % oint. (g), 0.1 % lotion, 0.1 % cream (g), 0.5 % oint. (g), 0.5 % cream (g))2 TRIANEX 0.05% ALTABAX 1% OINTMENT 4 clindamycin phosphate (1 % solution, 1 % lotion, 1 % med. swab, 1 % gel (gram), 1 % gel daily)2 erythromycin base in ethanol (in 2 % gel (gram), in 2 % solution)2 erythromycin base/ethanol 2 % solution 2 gentamicin sulfate (0.1 % oint. (g), 0.1 % cream (g))2 metronidazole (0.75 % gel (gram), 0.75 % cream (g), 0.75 % lotion, 1 % gel (gram), 1 % gel w/pump)2 mupirocin 2 % oint. (g) 1 mupirocin calcium 2 % cream (g) 2 ROSADAN 0.75% CREAM 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 60DRUG NAME DRUG TIERREQUIREMENTS/LIMITS selenium sulfide (2.5 % suspension, 2.5 % lotion) 2 silver sulfadiazine 1 % cream (g) 2 SSD 1% CREAM 2 sulfacetamide sodium 10 % suspension 2 DERMATOLOGICAL RETINOIDS adapalene (0.1 % cream (g), 0.1 % gel (gram), 0.3 % gel (gram), 0.3 % gel w/pump)2 AVITA 0.025% GEL 2 tazarotene 0.1 % cream (g) 2 TAZORAC (0.05% GEL, 0.1% GEL) 4 QL (30 GM PER 30 DAYS) TAZORAC 0.05% CREAM 4 tretinoin (0.01 % gel (gram), 0.025 % gel (gram), 0.025 % cream (g), 0.05 % cream (g), 0.1 % cream (g))2 tretinoin/emollient base 0.05 % cream (g) 2 SCABICIDES AND PEDICULICIDES EURAX (CREAM, LOTION) 4 malathion 0.5 % lotion 2 permethrin 5 % cream (g) 2 DEVICES HUMAPEN LUXURA HD 2 NOVOPEN ECHO INSULIN DEVICE 2 OMNIPOD (5 PACK POD, STARTER KIT) 2 OMNIPOD DASH 5 PACK POD 2 OMNIPOD DASH PDM KIT 2 V-GO 20 DISPOSABLE DEVICE 7 V-GO 30 DISPOSABLE DEVICE 7 V-GO 40 DISPOSABLE DEVICE 7 VGO 20 DISPOSABLE DEVICE 7 VGO 30 DISPOSABLE DEVICE 7 VGO 40 DISPOSABLE DEVICE 7 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 NAME DRUG TIERREQUIREMENTS/LIMITS ENZYME REPLACEMENT/MODIFIERS CERDELGA 84 MG CAPSULE 5 PA, NM CREON (DR 3,000 CAPSULE, DR 6,000 CAPSULE, DR 12,000 CAPSULE, DR 24,000 CAPSULE, DR 36,000 CAPSULE)3 CYSTAGON (50 MG CAPSULE, 150 MG CAPSULE)4 GALAFOLD 123 MG CAPSULE 5 PA, QL (14 CAPS PER 28 DAYS), NM KUVAN (100 MG TABLET, 100 MG POWDER PACKET, 500 MG POWDER PACKET)5 PA, LA, NM miglustat 100 mg capsule 5 LA, NM ORFADIN (2 MG CAPSULE, 4 MG/ML SUSPENSION, 5 MG CAPSULE, 10 MG CAPSULE, 20 MG CAPSULE)5 PA, LA, NM PULMOZYME 1 MG/ML AMPUL 5 30 DAYS), NM, BvsD REVCOVI 2.4 MG/1.5 ML VIAL 5 PA, NM STRENSIQ (18 MG/0.45 ML VIAL, 28 MG/0.7 ML VIAL, MG/ML VIAL, MG/0.8 ML VIAL)5 NM SUCRAID 8,500 UNITS/ML SOLN 5 PA, LA, NM EYE, EAR, NOSE, THROAT AGENTS EYE, EAR, NOSE, THROAT AGENTS, MISCELLANEOUS atropine sulfate 1 % drops 2 azelastine hcl (0.05 % drops, 137 mcg spray/pump)2 cromolyn sodium 4 % drops 1 CYSTARAN 0.44% EYE DROPS 5 PA, NM epinastine hcl 0.05 spray, 42 mcg spray)2 LACRISERT 5 MG EYE INSERT 4 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 62DRUG NAME DRUG TIERREQUIREMENTS/LIMITS olopatadine hcl (0.1 % drops, 0.2 % drops) 2 OXERVATE 0.002% EYE DROP 5 PA, NM EYE, EAR, NOSE, THROAT ANTI-INFECTIVES AGENTS acetic acid 2 % solution 2 acetic acid/aluminum acetate 2 % drops 2 AK-POLY-BAC EYE OINTMENT 2 bacitracin 500 unit/g 3 % drops moxifloxacin hcl 2 NATACYN EYE OINTMENT 2 polymyxin b sulf/trimethoprim 10000-1/ml drops 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 63DRUG NAME DRUG TIERREQUIREMENTS/LIMITS sulfacetamide sodium 10 % drops 2 sulfacetamide/prednisolone sp 10 %-0.23% drops 2 TOBRADEX EYE OINTMENT 3 tobramycin 0.3 % drops 2 tobramycin/dexamethasone 0.3 %-0.1% drops susp2 TOBREX 0.3% EYE 1 % drops 2 ZIRGAN 0.15% OPHTHALMIC GEL 3 EYE, EAR, NOSE, THROAT ANTI-INFLAMMATORY AGENTS bromfenac sodium 0.09 % drops 2 dexamethasone sodium phosphate 0.1 % drops 2 diclofenac sodium 0.1 % drops 2 DUREZOL 0.05% EYE DROPS 3 flunisolide 25 mcg spray 2 fluocinolone acetonide oil 0.01 % drops 2 fluorometholone 0.1 % drops susp 2 flurbiprofen sodium 0.03 % drops 1 2 PRED MILD 0.12% EYE DROPS 3 prednisolone acetate 1 % drops susp 2 prednisolone sod phosphate 1 % drops 2 prednisolone sodium phosphate 1 % drops 2 QNASL 80 MCG NASAL SPRAY 4 QNASL CHILDREN'S 40 MCG SPRAY 4 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January SUPPRESSANTS CARAFATE 1 GM/10 ML SUSP 4 cimetidine (200 mg tablet, 300 mg tablet, 400 mg tablet, 800 mg tablet)2 cimetidine hcl 300 mg/5ml solution 2 esomeprazole magnesium (20 mg capsule dr, 40 mg capsule dr)2 famotidine (20 mg tablet, 40 mg tablet) 1 lansoprazole (15 mg capsule dr, 30 mg capsule dr)2 misoprostol (100 mcg tablet, 200 mcg tablet) 2 omeprazole (10 mg capsule dr, 20 mg capsule dr, 40 mg capsule dr)1 pantoprazole sodium (20 mg tablet dr, 40 mg tablet dr)1 rabeprazole sodium 20 mg tablet dr 2 ranitidine hcl (150 mg tablet, 300 mg tablet) 1 ranitidine hcl 15 mg/ml syrup 2 sucralfate 1 g tablet 2 GASTROINTESTINAL AGENTS, OTHER AMITIZA (8 MCG CAPSULE, 24 MCG CAPSULES)3 QL (2 CAPS PER 1 DAY) CARBAGLU 200 MG DISPER TABLET 5 PA, LA, NM CHOLBAM (50 MG CAPSULE, 250 MG CAPSULE)5 PA, NM 10 GM/15 ML SOLN conc 2 PA dicyclomine hcl (10 mg/5 ml solution, 10 capsule, sulfate (hcl/atropine 2.5-.025mg tablet, hcl/atropine 2.5-.025/5 liquid)2 can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 65DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ENULOSE 10 GM/15 ML SOLUTION 2 GATTEX (5 MG ONE-VIAL KIT, 5 MG 30- VIAL KIT)5 PA, NM GENERLAC 10 GM/15 ML SOLUTION 2 glycopyrrolate (1 mg tablet, 2 mg tablet) 2 KIONEX (15 GM/60 ML SUSPENSION, POWDER)2 lactulose (10 ml 145 MCG CAPSULE, QL (1 CAP PER 1 DAY) loperamide hcl 2 mg capsule 2 methscopolamine bromide (2.5 mg tablet, 5 mg tablet)2 metoclopramide hcl (5 mg/5 ml solution, 5 mg tablet, 10 mg/10ml solution, 10 mg tablet)1 MOVANTIK (12.5 MG TABLET, 25 MG TABLET)4 PA, QL (30 TABS PER 30 DAYS) MYTESI 125 MG DR TABLET 3 PA OCALIVA (5 MG TABLET, 10 MG TABLET) 5 PA, NM RAVICTI 1.1 GRAM/ML LIQUID 5 PA, LA, NM sodium phenylbutyrate 500 mg tablet 5 PA, NM sodium polystyrene sulfonate (15 g/60 GM/120 ENEMA SUSP)2 SYMPROIC 0.2 MG TABLET 4 PA ursodiol (250 mg tablet, 300 mg capsule, 500 mg tablet)2 XERMELO 250 MG TABLET 5 PA, NM LAXATIVES GAVILYTE-C SOLUTION 2 GAVILYTE-G SOLUTION 2 GAVILYTE-N SOLUTION 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 66DRUG NAME DRUG KIT 4 TRILYTE WITH FLAVOR PACKETS 2 PHOSPHATE BINDERS calcium acetate 667 mg capsule 2 PHOSLYRA 667 MG/5 ML SOLUTION 3 sevelamer carbonate (0.8 g powd pack, 2.4 g powd pack)5 NM sevelamer ANTISPASMODICS, URINARY bethanechol chloride (5 mg tablet, 10 mg tablet, 25 mg tablet, 50 mg tablet)2 MYRBETRIQ (ER 25 MG TABLET, ER 50 MG TABLET)3 oxybutynin chloride (5 mg tablet, 5 mg/5 ml syrup, 5 mg tab er 24, 10 mg tab er 24, 15 mg tab er 24)2 tolterodine tartrate (1 mg tablet, 2 mg cap er 24h, 2 mg tablet, 4 mg cap er 24h)2 trospium chloride 20 mg tablet 2 GENITOURINARY AGENTS, MISCELLANEOUS alfuzosin hcl 10 mg tab er 24h 2 dutasteride 2 dutasteride/tamsulosin hcl 0.5-0.4 mg cpmp 24hr 2 finasteride 5 mg tablet 1 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 67DRUG NAME DRUG TIERREQUIREMENTS/LIMITS tamsulosin hcl (0.4 mg capsule, 0.4 mg cap er 24h)1 terazosin hcl (1 mg capsule, 2 mg capsule, 5 mg capsule, 10 mg capsule)1 THIOLA EC (EC 100 MG TABLET, EC 300 MG TABLET)5 PA, NM HEAVY METAL ANTAGONISTS CHEMET 100 MG CAPSULE 3 D-PENAMINE 125 MG TABLET 5 PA, NM deferasirox (125 mg tab disper, 250 mg tab disper, 500 mg tab disper)5 PA, NM DEPEN 250 MG TITRATAB 5 PA, NM FERRIPROX (100 MG/ML SOLUTION, 500 MG TABLET, 1,000 MG TABLET)5 PA, LA, NM JADENU (90 MG TABLET, 180 MG TABLET, 360 MG TABLET)5 PA, NM JADENU SPRINKLE (90 MG GRANULE, 360 MG GRANULE)5 PA, NM trientine hcl 250 5 PA, HORMONAL AGENTS, STIMULANT/REPLACEMENT/MODIFYING ANDROGENS ANADROL-50 TABLET 3 PA danazol (50 mg capsule, 100 mg capsule, 200 mg capsule)2 oxandrolone 10 mg tablet 2 PA, QL (2 TABS PER 1 DAY) oxandrolone 2.5 mg tablet 2 PA, QL (4 TABS PER 1 DAY) testosterone (1.25g-1.62 gel packet, 2.5g-1.62% gel packet, 10 mg (2%) gel md pmp, 12.5/1.25g gel md pmp, 20.25/1.25 gel md pmp, 25mg(1%) gel packet, 50 mg (1%) gel (gram), 50 mg (1%) gel packet)2 PA testosterone enanthate 200 mg/ml vial 2 PA You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January DRUG TIERREQUIREMENTS/LIMITS ESTROGENS AND ANTIESTROGENS AMABELZ TABLET, CLIMARA PRO PATCH 3 COMBIPATCH (0.05-0.25 MG, 0.05-0.14 MG) 3 DOTTI (0.025 MG PATCH, 0.0375 MG PATCH, 0.05 MG PATCH, 0.075 MG PATCH, 0.1 MG PATCH)2 estradiol tablet)2 estradiol (0.5 mg tablet, 1 mg tablet, 2 mg tablet) 1 estradiol/norethindrone acetate (estradiol/norethindrone 0.5-0.1 mg tablet, estradiol/norethindrone 1 mg-0.5mg TABLET)2 MIMVEY 1-0.5 MG tablet, tablet)2 PREMARIN (0.3 MG TABLET, 0.45 MG TABLET, 0.625 MG TABLET, 0.9 MG TABLET, 1.25 MG TABLET, VAGINAL CREAM-APPL)3 PREMPHASE 0.625-5 MG TABLET 3 PREMPRO (0.3 MG-1.5 MG TABLET, 0.45- 1.5 MG TABLET, 0.625-5 MG TABLET, 0.625-2.5 MG TABLET)3 raloxifene hcl 60 mg tablet 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 INSERT, 10 MCG TABLET)2 GLUCOCORTICOIDS/MINERALOCORTICOIDS DELTASONE 20 MG TABLET 1 PA - Part B vs D Determination dexamethasone (0.5 mg/5ml elixir, 0.5 mg/5ml solution, 0.5 mg tablet, 0.75 mg tablet, 1 mg tablet, 1.5 mg tablet, 2 mg tablet, 4 mg tablet, 6 mg tablet)2 PA - Part B vs D Determination DEXAMETHASONE INTENSOL 1 MG/ML 3 4 mg/ml vial, 10 mg/ml vial)2 fludrocortisone acetate 0.1 mg tablet 2 hydrocortisone (5 mg tablet, 10 mg tablet, 20 mg tablet)2 methylprednisolone (4 mg tablet, 8 mg tablet, 16 mg tablet, 32 mg tablet)2 PA - Part B vs D Determination methylprednisolone 4 mg tab ds pk 2 MILLIPRED 5 MG TABLET 3 PA - Part B vs D Determination MILLIPRED DP (5 MG 12-DAY PACK, 5 MG 6-DAY PACK)3 prednisolone 15 mg/5 ml solution 2 PA - Part B vs D Determination prednisolone sod phosphate 15 mg/5 ml solution 2 PA - Part B vs D Determination prednisolone sodium phosphate (5 mg/5 ml solution, 10 mg/5 ml solution, 15 mg/5 ml solution, 20 mg/5 ml solution, 25 mg/5 ml solution)2 PA - Part B vs D Determination prednisone (1 mg tablet, 2.5 mg tablet, 5 mg tablet, 10 mg tablet, 20 mg tablet, 50 mg tablet)1 PA - Part B vs D Determination prednisone (5 mg tab ds pk, 10 mg tab ds pk) 2 prednisone 5 mg/5 ml solution 2 PA - Part B vs D Determination PREDNISONE INTENSOL 5 MG/ML 3 PA - Part B vs D Determination SOLU-CORTEF (100 MG ACT-O-VIAL, 100 MG VIAL)4 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 10/spray tablet, 10/spray spray/pump)2 INCRELEX 40 MG/4 ML VIAL 5 PA, LA, NM LUPRON DEPOT-PED (11.25 MG KIT, 15 MG KIT)5 PA - FOR NEW STARTS ONLY, NM LUPRON DEPOT-PED 30 MG 3MO QL (28 TABS PER 28 DAYS), NM ORILISSA 200 MG TABLET 5 PA, QL (56 TABS PER 28 DAYS), NM SANDOSTATIN LAR DEPOT (10 MG KT, 10 MG VL, 20 MG KT, 20 MG VL, 30 MG KT, 30 MG VL)5 NM SEROSTIM (4 MG VIAL, 5 MG VIAL, 6 MG VIAL)5 PA, NM SIGNIFOR (0.3 MG/ML, PA, NM SOMATULINE DEPOT 120 MG/0.5 ML 5 PA - FOR NEW STARTS ONLY, NM SOMAVERT (10 MG VIAL, 15 MG VIAL, 20 MG VIAL, 25 MG VIAL, 30 MG VIAL)5 PA, LA, NM STIMATE 1.5 MG/ML NASAL SPRAY 4 SYNAREL 2 MG/ML NASAL SPRAY 5 PA - FOR NEW STARTS ONLY, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 71DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ZORBTIVE 8.8 MG VIAL 5 PA, NM PROGESTINS DEPO-PROVERA 400 MG/ML VIAL 4 PA - FOR NEW STARTS ONLY medroxyprogesterone acetate (150 mg/ml vial, 150 mg/ml syringe)2 medroxyprogesterone acetate (2.5 mg tablet, 5 mg tablet, 10 mg tablet)1 megestrol acetate 400mg/10ml oral susp 2 norethindrone acetate 5 mg tablet 2 progesterone, micronized (100 mg capsule, 200 mg capsule)2 THYROID AND ANTITHYROID AGENTS levothyroxine sodium (25 mcg tablet, 50 mcg tablet, 75 mcg tablet, 88 mcg tablet, 100 mcg tablet, 112 mcg tablet, 125 mcg tablet, 137 mcg tablet, 150 mcg tablet, 175 mcg tablet, 200 mcg tablet, 300 mcg tablet)2 liothyronine mcg tablet, 50 mcg tablet)2 methimazole (5 mg tablet, 10 mg tablet) 1 propylthiouracil 50 mg tablet 2 SYNTHROID (25 MCG TABLET, 50 MCG TABLET, 75 MCG TABLET, 88 MCG TABLET, 100 MCG TABLET, 112 MCG TABLET, 125 MCG TABLET, 137 MCG TABLET, 150 MCG TABLET, 175 MCG 200 MG/0.9 ML 5 PA, NM ARCALYST 220 MG INJECTION 5 PA, LA, NM AZASAN (75 MG TABLET, 100 MG TABLET)4 PA - Part B vs D Determination azathioprine 50 mg tablet 2 PA - Part B vs D Determination BIVIGAM LIQUID 10% VIAL 5 PA, LA, NM, BvsD You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 72DRUG NAME DRUG TIERREQUIREMENTS/LIMITS CIMZIA (200 MG/ML STARTER KIT, 200 SYRINGE MG VIAL KIT)5 PA, NM CUTAQUIG ((1 G/6 ML) VIAL, (1.65 G/10 (2 ML) VL, (3.3 G/20 ML), ML VIAL, 2 GRAM/10 ML VIAL, 4 GRAM/20 ML VIAL, 8 GRAM/ 40 ML VIAL, 10 GRAM/50 ML VIAL)5 PA, NM, BvsD cyclosporine (25 mg capsule, 100 mg capsule) 2 PA - Part B vs D Determination cyclosporine 250 mg/5ml ampul 1 PA - Part B vs D Determination cyclosporine, modified (25 mg capsule, 50 mg capsule, 100 mg capsule, 100 mg/ml solution)2 PA - Part B vs D Determination DUPIXENT 200 MG/1.14 ML SYRING 5 PA, NM ENBREL SYRINGE)5 PA, ENBREL BvsD GAMMAKED GRAM/10 ML VIAL, GRAM/25 ML VIAL, 5 GRAM/50 ML VIAL, 10 GRAM/100 ML VIAL, 20 GRAM/200 ML VIAL)5 PA, NM, BvsD GAMMAPLEX (2.5 GRAM/50 ML VIAL, 5 GRAM/100 ML VIAL, 5 GRAM/50 ML VIAL, 10 GRAM/100 ML VIAL, 10 GRAM/200 ML VIAL, 20 GRAM/200 ML VIAL, 20 GRAM/400 ML VIAL)5 PA, NM, BvsD GAMUNEX-C (1 GRAM/10 ML VIAL, 2.5 GRAM/25 ML VIAL, 5 GRAM/50 ML VIAL, 10 GRAM/100 ML VIAL, 20 GRAM/200 ML VIAL, 40 GRAM/400 ML VIAL)5 PA, NM, BvsD GENGRAF (25 MG CAPSULE, 100 MG/ML SOLUTION, 100 MG CAPSULE)2 PA - Part B vs D Determination You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 73DRUG NAME DRUG TIERREQUIREMENTS/LIMITS HIZENTRA (1 GRAM/5 ML VIAL, 2 GRAM/10 ML VIAL, 4 GRAM/20 ML VIAL, 10 GRAM/50 ML PA, MG/0.8 ML 5 PA, NM HUMIRA CROHN-UC-HS 40 MG 5 PA, NM HUMIRA PS-UV-ADOL HS 40 MG HYQVIA (2.5 UNIT PACK, 5 GM- 400 UNIT PACK, 10 GM-800 UNIT PACK, 20 GM-1,600 UNIT PACK, 30 GM-2,400 UNIT PACK)5 PA, NM, ML PEN INJ, 150 SYRINGE 5 PA, NM leflunomide (10 mg tablet, 20 mg tablet) 2 mycophenolate mofetil (250 mg capsule, 500 mg tablet)2 PA - Part B vs D Determination mycophenolate mofetil 200 mg/ml susp recon 5 PA - vs D Determination, NM OCTAGAM (5% VIAL, 10% VIAL) 5 PA, TABLET PA, MG/ML SYRINGE)5 PA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January ORENCIA CLICKJECT 125 MG/ML 5 PA, NM OTEZLA STARTER PACK, 30 MG TABLET)5 PA, NM OTEZLA STARTER PACK 5 NM PANZYGA ((1 G/10 ML) VIAL, (10 G/100 ML) VIAL, (20 G/200 ML) VIAL, (30 G/300 ML) VIAL, (2.5 G/25 ML) (5 G/50 ML) GRANULE PACKET, 1 MG GRANULE PACKET)5 PA - Part B vs D Determination, NM RASUVO (7.5 MG/0.15 ML, 10 MG/0.2 ML, 12.5 MG/0.25 ML, 15 MG/0.3 ML, 17.5 MG/0.35 ML, 20 MG/0.4 ML, 22.5 MG/0.45 ML, 25 MG/0.5 ML, 30 MG/0.6 ML)4 PA RIDAURA 3 MG CAPSULE NM ML INJEC, SYRINGE)5 PA, NM sirolimus (0.5 mg tablet, 1 mg tablet) 2 PA - Part B vs D Determination sirolimus (1 mg/ml solution, 2 mg tablet) 5 PA - Part B vs D Determination, NM SKYRIZI 75 MG/0.83 ML SYRINGE MG/ML SYRINGE)5 PA, NM tacrolimus (0.5 mg capsule, 1 mg capsule, 5 mg capsule)2 PA - Part B vs D Determination VARIZIG (125 UNIT VIAL, 125 UNIT/1.2 ML VIAL)3 XELJANZ (5 MG TABLET, 10 MG TABLET) 5 PA, NM XELJANZ XR 11 MG TABLET 5 PA, NM ZORTRESS (0.5 MG TABLET, 0.75 MG TABLET, 1 MG TABLET)5 PA - FOR NEW STARTS ONLY, NM, BvsD ZORTRESS 0.25 MG TABLET 3 PA - FOR NEW STARTS ONLY, BvsD VACCINES ACTHIB (VIAL, WITH DILUENT) 3 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 ADACEL TDAP (SYRINGE, VIAL) 3 bcg vaccine, live/pf 50 mg vial 3 PA - Part B vs D Determination BEXSERO PREFILLED SYRINGE 3 MCG/ML SYRN, 20 MCG/ML VIAL)3 PA - B vs D Determination ENGERIX-B PEDI 10 MCG/0.5 SYRN 3 PA - Part B vs D Determination GARDASIL 9 (9 SYRINGE, 9 VIAL) 3 HAVRIX (720 RABIES VACCINE (VACCINE VIAL, VACCINE+DILUENT)3 PA - Part B vs D Determination INFANRIX DTAP (SYRINGE, VIAL) 3 IPOL VIAL 3 MENVEO VIAL KT 3 SYRINGE 3 VIAL PENTACEL COMPONENT VIAL 3 PENTACEL DTAP-IPV COMPONENT VL VIAL KIT VIAL 3 RABAVERT (VACC W-DILUENT, VACCINE VIAL)3 PA Part B vs Determination RECOMBIVAX HB (5 MCG/0.5 ML VL, MCG/ML SYR, 40 MCG/ML VIAL)3 PA - Part B vs D Determination You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 76DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ROTARIX VACCINE SUSPENSION 3 ROTATEQ VACCINE 3 SHINGRIX GE ANTIGEN COMPONENT 3 SHINGRIX VIAL KIT 3 TENIVAC (SYRINGE, VIAL) 3 VACCINE SYRINGE 3 AL, 25 MCG/0.5 ML SYRNG)3 VAQTA (25 DILUENT)3 YF-VAX (1 VIAL, 5 VIAL) 3 ZOSTAVAX VIAL 3 INFLAMMATORY BOWEL DISEASE AGENTS alosetron hcl (0.5 mg tablet, 1 mg tablet) 5 PA, NM balsalazide disodium 750 mg capsule 2 budesonide 3 mg capdr - er 2 COLOCORT 100 MG ENEMA 2 hydrocortisone 100mg/60ml enema 2 mesalamine (1.2 g tablet dr, 4 g/60 ml enema, 400 mg cap(drtab), 800 mg g/60 ml enema kit 2 sulfasalazine (500 mg tablet, 500 mg tablet dr) 2 IRRIGATING SOLUTIONS water for irrigation,sterile irrig soln 2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 77DRUG NAME DRUG TIERREQUIREMENTS/LIMITS METABOLIC BONE DISEASE AGENTS alendronate sodium (5 mg tablet, 10 mg tablet, 35 mg tablet, 40 mg tablet, 70 mg tablet)1 alendronate sodium 70 mg/75ml solution 2 mcg/ml solution)2 cinacalcet hcl mg tablet, 90 mg tablet) NM cinacalcet hcl 30 mg tablet 2 etidronate disodium (200 mg tablet, 400 mg tablet)2 FORTEO 600 MCG/2.4 ML PEN INJ 5 PA, NM ibandronate sodium 150 mg tablet 2 NATPARA (25 MCG CARTRIDGE, 50 MCG CARTRIDGE, 75 PA, mcg capsule)2 PA, BvsD risedronate sodium (5 mg tablet, 30 mg tablet, 35 mg tablet, 150 mg tablet)2 TYMLOS 80 MCG DOSE PEN INJECTR 5 PA, NM XGEVA 120 MG/1.7 ML VIAL 5 PA, NM MISCELLANEOUS THERAPEUTIC AGENTS ACTIMMUNE 100 MCG/0.5 ML VIAL 5 PA - FOR NEW STARTS ONLY, NM BENLYSTA (200 MG/ML SYRINGE, 200 MG/ML AUTOINJECT)5 PA, NM MG 11 MG KIT) 5 PA, NM CYSTADANE 1 GRAM/1.7 ML POWDER 5 LA, NM ELMIRON 100 MG CAPSULE 5 NM FIRDAPSE 10 MG TABLET 5 PA, NM GLUCAGEN DIAGNOSTIC 1 MG VIAL 3 glucagon hcl 1 mg vial 3 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 78DRUG NAME DRUG TIERREQUIREMENTS/LIMITS guanidine hcl 125 mg tablet 2 hydroxyzine pamoate (25 mg capsule, 50 mg capsule, 100 mg capsule)1 KALBITOR 10 MG/ML VIAL 5 PA, LA, NM leucovorin calcium (5 mg tablet, 10 mg tablet, 15 mg tablet, 25 mg tablet)2 levocarnitine (with sugar) 100 mg/ml solution 2 levocarnitine 330 mg tablet 2 MESNEX 400 MG TABLET 5 PROGLYCEM 50 MG/ML ORAL SUSP 5 NM pyridostigmine bromide (30 mg tablet, 60 mg tablet, 60 mg/5 ml syrup, 180 mg tablet er)2 RECTIV 0.4% OINTMENT 4 RUZURGI 10 MG TABLET 5 PA, NM TAKHZYRO 300 MG/2 ML VIAL 5 PA, LA, QL (4 ML PER 30 DAYS), NM THALOMID (50 MG CAPSULE, 100 MG CAPSULE, 150 MG CAPSULE, 200 MG CAPSULE)5 NM THIOLA 100 MG TABLET 5 PA, NM TYBOST 150 MG TABLET 3 VISTOGARD 10 GRAM PACKET 5 PA, NM OPHTHALMIC AGENTS ANTIGLAUCOMA AGENTS acetazolamide (125 mg tablet, 250 mg tablet, 500 mg capsule er)2 ALPHAGAN P 0.1% DROPS 4 AZOPT 1% EYE DROPS betaxolol hcl 0.5 % drops 2 BETOPTIC S 0.25% EYE DROPS 4 bimatoprost 0.03 % drops 2 brimonidine tartrate (0.15 % drops, 0.2 % drops) 2 carteolol hcl 1 % drops 1 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January 1, 2020 DRUG TIERREQUIREMENTS/LIMITS COMBIGAN 0.2%-0.5% EYE DROPS 0.005 % levobunolol hcl 0.5 % drops 1 LUMIGAN 0.01% EYE DROPS 3 methazolamide (25 mg tablet, 50 mg tablet) 2 PHOSPHOLINE IODIDE 0.125% 4 pilocarpine hcl (1 % drops, 2 % drops, 4 % drops) 2 SIMBRINZA 1%-0.2% EYE DROPS 3 timolol maleate (0.25 % drops, 0.5 % drops) 1 timolol maleate (0.25 % sol-gel, 0.5 % drop daily, 0.5 % sol-gel)2 TRAVATAN Z 0.004% EYE DROP 3 REPLACEMENT PREPARATIONS 0.9 % sodium chloride (0.9 % 0.9 % iv soln, 0.9 % pggybk prt, 0.9 % 0.9 % vial, 0.9 % pgy vl prt)2 dextrose 10 % and 0.45 % nacl 10%-0.45% iv soln 2 dextrose 2.5 % and 0.45 % nacl 2.5%-0.45% iv soln2 dextrose 5 % and 0.9 % 5 %-0.9 iv soln 2 dextrose 2 KLOR-CON SPRINKLE ER 8 MEQ CAP 2 magnesium sulfate (4 meq/ml vial, 4 meq/ml syringe)2 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 80DRUG NAME DRUG TIERREQUIREMENTS/LIMITS potassium chloride meq/ml vial, 2 ampul)1 potassium chloride (8 meq tablet er, 8 meq capsule er, 10 meq capsule er, 10 meq tab er prt, 10 meq tablet er, 20 meq packet, 20 meq tablet er, 20meq/15ml liquid, 20 meq tab er prt, 40meq/15ml liquid)2 potassium chloride in 5 % dextrose in water (in 20 meq/l iv soln, in 30 meq/l iv soln, in 40 meq/l iv soln)2 potassium chloride in dextrose 5 % and % chloride 40 iv meq/l iv soln 2 potassium chloride in water for injection, (in potassium citrate (5 tablet er, 10 tablet er, 15 tablet er)2 sodium chloride 0.45 % (0.45 % pggybk prt, 0.45 % 0.45 % iv soln)2 sodium chloride 2.5 meq/ml vial 2 sodium chloride 3 % 3 % iv soln 2 sodium chloride 5 % 5 % iv soln 2 RESPIRATORY #120)3 can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 ampul-neb)2 B (4 mg gran pack, 4 mg tab chew, 5 mg tab chew)2 montelukast sodium 10 mg tablet 1 zileuton 600 PA - Part B vs D Determination albuterol sulfate (2 mg/5 ml syrup, 2 mg tablet, 4 mg tab er 12h, 4 mg tablet, 8 mg tab er 20-100 MCG 3 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 January MCG INH 3 ipratropium bromide 0.2 mg/ml solution 2 PA - Part B vs D Determination ipratropium/albuterol sulfate 0.5-3mg/3 ampul- neb2 PA - Part B vs D Determination tartrate 45 mcg hfa anhydrous (100 mg tab er 12h, 200 mg tab er 12h, 300 mg tab er 12h, 400 mg tab er 24h, 450 mg tab er 12h, 600 mg tab er 24h)2 TRELEGY ELLIPTA 100-62.5-25 3 RESPIRATORY TRACT AGENTS, OTHER acetylcysteine (100 mg/ml vial, 200 mg/ml vial) 2 PA - Part B vs D Determination ARALAST NP (500 MG VIAL, 1,000 MG VIAL)5 PA, LA, NM cromolyn sodium 20 mg/2 ml ampul-neb 2 PA - Part B vs D Determination DALIRESP (250 MCG TABLET, 500 MCG TABLET)3 PA ESBRIET (267 MG TABLET, 267 MG CAPSULE, 801 MG TABLET)5 PA, NM GLASSIA 1 GM/50 ML VIAL 5 PA, LA, NM KALYDECO (25 MG GRANULES PACKET, 50 MG GRANULES PACKET, 75 MG GRANULES PACKET, 150 MG TABLET)5 PA, NM NUCALA (100 MG/ML MG/ML PA, NM MG MG PA, VIAL, 1,000 MG VIAL)5 PA, NM PROLASTIN C (MG MG TABS)5 PA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, XOLAIR ML VIAL)5 PA, LA, NM ZEMAIRA 1,000 MG VIAL 5 PA, LA, NM SKELETAL MUSCLE RELAXANTS baclofen (5 mg tablet, 10 mg tablet, 20 mg tablet) 2 cyclobenzaprine hcl (5 mg tablet, 10 mg tablet) 1 PA dantrolene sodium (25 mg capsule, 50 mg capsule, 100 mg capsule)2 tizanidine hcl (2 mg tablet, 4 mg tablet) 2 SLEEP DISORDER AGENTS armodafinil (150 mg tablet, 200 mg tablet, 250 mg tablet)2 PA, QL (30 TABS PER 30 DAYS) armodafinil 50 mg tablet 2 PA, QL (60 TABS PER 30 DAYS) BELSOMRA (5 MG TABLET, 10 MG TABLET, 15 MG TABLET, 20 MG TABLET)4 eszopiclone (1 mg tablet, 2 mg tablet) 2 QL (30 TABS PER 30 DAYS) HETLIOZ 20 MG CAPSULE 5 PA, NM modafinil (100 mg tablet, 200 mg tablet) 2 PA, QL (60 TABS PER 30 DAYS) XYREM 500 MG/ML ORAL SOLUTION 5 PA, LA, QL (18 ML PER 1 DAY), NM zaleplon (5 mg capsule, 10 mg capsule) 2 QL (30 CAPS PER 30 DAYS) zolpidem tartrate (5 mg tablet, 10 mg tablet) 1 QL (30 TABS PER 30 DAYS) zolpidem tartrate (6.25 mg tab mphase, 12.5 mg tab mphase)2 ST, QL (30 TABS PER 30 DAYS) VASODILATING AGENTS ADEMPAS (0.5 MG TABLET, 1 MG TABLET, 1.5 MG TABLET, 2 MG TABLET, 2.5 MG TABLET)5 PA, NM ambrisentan (5 mg tablet, 10 mg tablet) 5 PA, LA, NM bosentan (62.5 mg tablet, 125 mg tablet) 5 PA, LA, NM LETAIRIS (5 MG TABLET, 10 MG TABLET) 5 PA, LA, NM OPSUMIT 10 MG TABLET 5 PA, NM You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 84DRUG NAME DRUG TIERREQUIREMENTS/LIMITS ORENITRAM ER (ER 0.25 MG TABLET, ER 1 MG TABLET, ER 2.5 MG TABLET, ER 5 MG TABLET)5 PA, NM ORENITRAM ER 0.125 MG TABLET 4 PA sildenafil 20 mg tablet (generic for revatio) 2 PA tadalafil 20 mg tablet 5 PA, NM tadalafil 20 mg tablet (generic for adcirca) 5 PA, NM TRACLEER 32 MG TABLET FOR SUSP 5 PA, LA, NM TYVASO 1.74 MG/2.9 ML SOLUTION PA, LA, (200 MCG TABLET, 200-800 TITRATION PACK, 400 600 MCG TABLET, 800 MCG TABLET, 1,000 MCG TABLET, 1,200 MCG 1,400 1,600 MCG PA, (10 SOLUTION)5 PA, LA, NM, BvsD VITAMINS AND MINERALS CITRANATAL BLOOM TABLET 1 You can find information on what the symbols and abbreviations on this table mean by going to page I-7. 2020 Medicare Drug Formulary Formulary ID 00020203, Version 7 Effective: January 1, 2020 85Index of Covered Drugs In this section, you can find a drug by searching its name alphabetically. This will tell you the page number where you can find additional coverage information for your drug. 0 0.9 % sodium chloride 80 A abacavir sulfate 34 acarbose 23 acetaminophen with codeine phosphate 1 acetazolamide 79 acetic acid 63 acetic acid/aluminum acetate 63 acetylcysteine 83 acitretin 58 M 9 LO dextrose BLOOM 85 CLARAVIS (2 SYRINGES) 58 PEN COSENTYX (2 58 SYRINGE COTELLIC 84 cyclophosphamide cycloserine cyclosporine cyproheptadine 27 53 CYRED mg tablet (generic for Pristiq) 21 desvenlafaxine suc er 25 mg tablet (generic for Pristiq) 21 desvenlafaxine suc er 50 mg tablet (generic 21 70 DEXAMETHASONE INTENSOL 10 % and 0.45 % sodium chloride 80 dextrose 10 % in water 41 dextrose 2.5 % and 0.45 % sodium chloride 80 dextrose 5 % and 0.45 % sodium chloride 80 dextrose 5 % and 0.9 % sodium chloride 80 dextrose 5 % in lactated ringers 80 dextrose 5 % in water 41 DIASTAT 6 DIASTAT ACUDIAL diazepam 6,18 DILT-XR diltiazem 24hr er 360 mg cap for diltiazem hcl 46 59 fluocinonide/emollient base 59 fluoride fluorometholone HIBERIX 74 74 74 HUMIRA(CF) PEN CROHN'S-UC-HS 74 HUMIRA(CF) PEN PSOR-UV-ADOL HS 74 HUMULIN U-500 HUMULIN HYQVIA 78 IBRANCE 13 IBU 3 ibuprofen 3 14 insulin lispro 25 INTELENCE ISENTRESS 0.9 % sodium chloride 7 linezolid in dextrose 5 % in water 7 LINZESS 66 liothyronine sodium 72 lisinopril 43 lisinopril/hydrochlorothiazide 43 lithium carbonate 51 lithium citrate 51 55 14 M M-M-R VACCINE magnesium 80 61 22 22 MATULANE 15 MATZIM LA 46 MATZIM LA 360 MG TABLET (GENERIC FOR CARDIZEM LA) 46 MAVENCLAD 51 MAVYRET 37 0.9 % sodium chloride 9 mesalamine 77 mesalamine with cleansing wipes 77 MESNEX 79 metformin hcl 24 metformin hcl 1,000 mg tablet (generic for glucophage) 24 metformin hcl 500 mg tablet (generic METHADONE 65 PEGASYS 38 PEGASYS PROCLICK 38 PEGINTRON 38 penicillin g potassium 10 penicillin g potassium/dextrose-water 10 penicillin v potassium 10PENTACEL 76 PENTACEL ACTHIB COMPONENT PENTACEL PLEGRIDY POLYCIN polyethylene 3350 b POMALYST 15 PORTIA 56 posaconazole 27 potassium chloride 81 potassium chloride in 5 % dextrose in water 81 potassium chloride in dextrose 5 % and 0.9 % sodium chloride 81 potassium chloride in dextrose 5 %-0.45 % sodium chloride 81 potassium chloride in lactated ringers and 5 % dextrose 81 potassium chloride in water for injection, sterile 81 potassium citrate 81 PRADAXA 39 pramipexole di-hcl 79 16 31 SANDOSTATIN 67 56 77 SHINGRIX GE ANTIGEN COMPONENT 77 SIGNIFOR 71 sildenafil 20 mg tablet (generic for revatio) 85 59 sulfadiazine 7 SKYRIZI 75 sodium chloride 81 sodium chloride 0.45 % 81 sodium chloride 3 % 81 sodium chloride 5 % 81 sodium chloride/sodium bicarbonate/potassium chloride/peg 67 sodium phenylbutyrate 66 sodium 37 SOLTAMOX 75 36 LO SYMLINPEN 24 60 SYMPAZAN 16 tacrolimus 60,75 tadalafil 85 tadalafil 20 mg tablet (generic 16 TRI-LINYAH valganciclovir hcl valproic acid valproic acid (as sodium salt) (valproate sodium) 20 valsartan 42 valsartan/hydrochlorothiazide 43 vancomycin hcl 8 77 47 VYNDAQEL 47 VYVANSE 52 W warfarin 39 water for irrigation,sterile 77 WERA 57 WIXELA 82 105This formulary was updated on 08/27/2019. For more recent information or other questions, please contact HealthPartners Member Services. Freedom members: users: 711 Or healthpartners.com/medicarerx . From Oct. 1 through March 31 , we take call s from 8 a.m. to 8 p.m. CT, seven days a week . You'll speak with a representative. From April 1 t hrough Sept. 30 , call us 8 a.m. t o 8 p.m. CT, Monday through Friday to spea k with a representativ e. On Saturdays, Sunday s and Federal holidays, you can leave a message and we'll get back to you within one "}